EP2151431A1 - Amide compound and use thereof - Google Patents

Amide compound and use thereof Download PDF

Info

Publication number
EP2151431A1
EP2151431A1 EP08752105A EP08752105A EP2151431A1 EP 2151431 A1 EP2151431 A1 EP 2151431A1 EP 08752105 A EP08752105 A EP 08752105A EP 08752105 A EP08752105 A EP 08752105A EP 2151431 A1 EP2151431 A1 EP 2151431A1
Authority
EP
European Patent Office
Prior art keywords
group
compound
formula
atom
amide compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP08752105A
Other languages
German (de)
French (fr)
Other versions
EP2151431A4 (en
Inventor
Takashi Komori
Mayumi Kubota
Yuichi Matsuzaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Publication of EP2151431A1 publication Critical patent/EP2151431A1/en
Publication of EP2151431A4 publication Critical patent/EP2151431A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/54—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/36—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids
    • A01N37/38—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids having at least one oxygen or sulfur atom attached to an aromatic ring system
    • A01N37/40—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids having at least one oxygen or sulfur atom attached to an aromatic ring system having at least one carboxylic group or a thio analogue, or a derivative thereof, and one oxygen or sulfur atom attached to the same aromatic ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/46—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Definitions

  • the present invention relates to an amide compound and use thereof.
  • Drugs for controlling plant diseases have been conventionally developed. Compounds having plant disease controlling activity have been found out and have been put into practice.
  • An object of the present invention is to provide a compound having excellent plant disease controlling activity.
  • the present invention provides an amide compound represented by the formula (1): wherein, X 1 represents a fluorine atom or a methoxy group, X 2 represents a chlorine atom, a bromine atom, an iodine atom, a C 1 -C 4 alkyl group, a C 2 -C 4 alkenyl group, a C 2 -C 4 alkynyl group, a C 1 -C 4 haloalkyl group, a C 2 -C 4 alkoxy group, a C 1 -C 4 alkylthio group, a hydroxy C 1 -C 4 alkly group, a nitro group, a cyano group, a formyl group, a NR 1 R 2 group, a CO 2 R 3 group,
  • the compound of the present invention has excellent plant disease controlling activity and therefore, it is useful as an active ingredient of a plant disease controlling agent.
  • examples of the C 1 -C 4 alkyl group represented by X 2 include a methyl group, an ethyl group, a 1-methylethyl group, a 1,1-dimethylethyl group, a propyl group and a 1-methylpropyl group.
  • examples of the C 2 -C 4 alkenyl group represented by X 2 include a vinyl group, a 1-propenyl group, a 2-propenyl group, a 2-butenyl group and a 3-butenyl group.
  • Examples of the C 2 -C 4 alkynyl group represented by X 2 include an ethynyl group, a 1-propynyl group, a 2-propynyl group, a 3-butynyl group.
  • Examples of the C 1 -C 4 haloalkyl group represented by X 2 include a fluoromethyl group, a chloromethyl group, a bromomethyl group, a difluoromethyl group, a dichloromethyl group, a dibromomethyl group, a trifluoromethyl group, a trichloromethyl group, a dichlorofluoromethyl group, a chlorodifluoromethyl group, a 1,1-difluoroethyl group, a 2,2,2-trifluoroethyl group, a 2-fluoroethyl group, a 3-fluoropropyl group, a 4-fluorobutyl group and a 1-chloroethyl group.
  • Examples of the C 2 -C 4 alkoxy group represented by X 2 include an ethoxy group, a 1-methylethoxy group, a 1,1-dimethylethoxy group, a propoxy group, a 1-methylpropoxy group, a 2-methylpropoxy group and a butoxy group.
  • Examples of the C 1 -C 4 alkylthio group represented by X 2 include a methylthio group, an ethylthio group, a 1-methylethylthio group, a 1,1-dimethylethylthio group, a propylthio group and a 1-methylpropylthio group.
  • Examples of the hydroxyl C 1 -C 4 alkyl group represented by X 2 include a hydroxymethyl group, a 1-hydroxyethyl group and a 2-hydroxyethyl group.
  • Examples of the phenyl group optionally substituted with at least one group selected from the group consisting of a methyl group, a halogen atom, a cyano group and a nitro group which is represented by X 2 include a phenyl group, a 2-methylphenyl group, a 3-methylphenyl group, a 4-methylphenyl group, a 2-fluorophenyl group, a 3-fluorophenyl group, a 4-fluorophenyl group, a 2-chlorophenyl group, a 3-chlorophenyl group, a 4-chlorophenyl group, a 4-cyanophenyl group and a 4-nitrophenyl group.
  • Examples of the C 1 -C 4 alkyl group represented by R 1 include a methyl group, an ethyl group, a 1-methylethyl group, a 1,1-dimethylethyl group, a propyl group and a 1-methylpropyl group.
  • Examples of the C 3 -C 4 alkenyl group represented by R 1 include a 1-propenyl group, a 2-propenyl group, a 2-butenyl group and a 3-butenyl group.
  • Examples of the C 3 -C 4 alkynyl group represented by R 1 include a 1-propynyl group, a 2-propynyl group and a 3-butynyl group.
  • Examples of the C 2 -C 4 haloalkyl group represented by R 1 include a 1,1-difluoroethyl group, a 2,2,2-trifluoroethyl group, a 2-fluoroethyl group, a 3-fluoropropyl group, a 4-fluorobutyl group and a 1-chloroethyl group.
  • Examples of the C 2 -C 5 alkylcarbonyl group represented by R 1 include an acetyl group, an ethylcarbonyl group, a 1-methylethyloarboryl group and a 1,1-dimethylethylcarbonyl group.
  • Examples of the C 2 -C 5 alkoxycarbonyl group represented by R 1 include a methoxycarbonyl group, an ethoxycarbonyl group, a 1-methylethoxycarbonyl group and a 1,1-dimethylethoxycarbonyl group.
  • Examples of the C 1 -C 4 alkylsulfonyl group represented by R 1 include a methylsulfonyl group, an ethylsulfonyl group, a 1-methylethylsulfonyl group and a 1,1-dimethylethylsulfonyl group.
  • Examples of the C 1 -C 4 alkyl group represented by R 2 include a methyl group, an ethyl group, a 1-methylethyl group, a 1,1-dimethylethyl group, a propyl group and a 1-methylpropyl group.
  • Examples of the C 3 -C 4 alkenyl group represented by R 2 include a 1-propenyl group, a 2-propenyl group, a 2-butenyl group and a 3-butenyl group.
  • Examples of the C 3 -C 4 alkynyl group represented by R 2 include a 1-propynyl group, a 2-propynyl group and a 3-butynyl group.
  • Examples of the C 2 -C 4 haloalkyl group represented by R 2 include a 1,1-difluoroethyl group, a 2,2,2-trifluoroethyl group, a 2-fluoroethyl group, a 3-fluoropropyl group, a 4-fluorobutyl group and a 1-chloroethyl group.
  • Examples of the C 2 -C 5 alkylcarbonyl group represented by R 2 include an acetyl group, an ethylcarbonyl group, a 1-methylethylcarbonyl group and a 1,1-dimethylethylcarbonyl group.
  • Examples of the C 2 -C 5 alkoxycarbonyl group represented by R 2 include a methoxycarbonyl group, an ethoxycarbonyl group, a 1-methylethoxycarbonyl group and a 1,1-dimethylethoxycarbonyl group.
  • Examples of the C 1 -C 4 alkylsulfonyl group represented by R 2 include a methylsulfonyl group, an ethylsulfonyl group, a 1-methylethylsulfonyl group and a 1,1-dimethylethylsulfonyl group.
  • Examples of the C 1 -C 4 alkyl group represented by R 3 include a methyl group, an ethyl group, a 1-methylethyl group, a 1,1-dimethylethyl group, a propyl group, and a 1-methylpropyl group.
  • Examples of the C 3 -C 4 alkenyl group represented by R 3 include a 1-propenyl group, a 2-propenyl group, a 2-butenyl group and a 3-butenyl group.
  • Examples of the C 3 -C 4 alkynyl group represented by R 3 include a 1-propynyl group, a 2-propynyl group, and a 3-butynyl group.
  • Examples of the C 1 -C 4 alkyl group represented by R 4 include a methyl group, an ethyl group, a 1-methylethyl group, a 1,1-dimethylethyl group, a propyl group and a 1-methylpropyl group.
  • Examples of the C 3 -C 4 alkenyl group represented by R 4 include a 1-propenyl group, a 2-propenyl group, a 2-butenyl group and a 3-butenyl group.
  • Examples of the C 3 -C 4 alkynyl group represented by R 4 include a 1-propynyl group, a 2-propynyl group, and a 3-butynyl group.
  • Examples of the C 2 -C 4 haloalkyl group represented by R 4 include a 1,1-difluoroethyl group, a 2,2,2-trifluroethyl group, a 2-fluoroethyl group, a 3-fluoropropyl group, a 4-fluorobutyl group, and a 1-chloroethyl group.
  • Examples of the C 2 -C 5 alkylcarbonyl group represented by P 4 include an acetyl group, an ethylcarbonyl group, a 1-methylethylcarbonyl group and a 1,1-dimethylethylcarbonyl group.
  • Examples of the C 2 -C 5 alkoxycarbonyl group represented by R 4 include a methoxycarbonyl group, an ethoxycarbornyl group, a 1-methylethoxycarbonyl group and a 1,1-dimethylethoxycarbonyl group.
  • Examples of the C 1 -C 4 alkylsulfonyl group represented by R 4 include a methylsulfonyl group, an ethylsulfonyl group, a 1-methylethylsulfonyl group and a 1,1-dimethylethylsulfonyl group.
  • Examples of the C 1 -C 4 alkyl group represented by R 5 include a methyl group, an ethyl group, a 1-methylethyl group, a 1,1-dimethylethyl group, a propyl group, and a 1-methylpropyl group.
  • Examples of the C 3 -C 4 alkenyl group represented by R 5 include a 1-propenyl group, a 2-propenyl group, a 2-butenyl group and a 3-butenyl group.
  • Examples of the C 3 -C 4 alkynyl group represented by R 5 include a 1-propynyl group, a 2-propynyl group and a 3-butynyl group.
  • Examples of the C 2 -C 4 haloalkyl group represented by R 5 include a 1,1-difluoroethyl group, a 2,2,2-trifluoroethyl group, a 2-fluoroethyl group, a 3-fluoropropyl group, a 4-fluorobutyl group and a 1-chloroethyl group.
  • Examples of the NR 1 R 2 group include an amino group, a methylamino group, a dimethylamino group, an ethylamino group, a 2-propenylamino group, a propynylamino group, a 2-chloroethylamino group, an acetylamino group, a propionylamino group, a 1,1-dimethylethylcarbonylamino group, a methoxycarbonylamino group, an ethoxycarbonylamino group, a methanesulfonylamino group, an N-acetyl-N-methylamino group, an N-ethoxycarbonyl-N-methylamino group and an N-methanesulfonyl-N-methylamino group.
  • Examples of the CONR 4 R 5 group include a carbamoyl group, a methylcarbamoyl group, a dimethylcarbamoyl group, an ethylmethylcarbamoyl group, a (2-propenyl)carbamoyl group, a (2-propynyl)carbamoyl group and a 2-chloroethylcarbamoyl group.
  • Examples of the C 1 -C 4 alkyl group represented by R 11 include a methyl group, an ethyl group, a 1-methylethyl group, a 1,1-dimethylethyl group, a propyl group, and a 1-methylpropyl group.
  • Examples of the C 1 -C 4 alkyl group represented by R 12 include a methyl group, an ethyl group, a 1-methylethyl group, a 1,1-dimethylethyl group, a propyl group, and a 1-methylpropyl group.
  • Examples of the C 1 -C 4 alkyl group represented by R 13 include a methyl group, an ethyl group, a 1-methylethyl group, a 1,1-dimethylethyl group, a propyl group, and a 1-methylpropyl group.
  • Examples of the C 2 -C 4 alkenyl group represented by R 13 include a vinyl group, a 1-propenyl group, a 2-propenyl group, a 2-butenyl group and a 3-butenyl group.
  • Examples of the C 2 -C 4 alkynyl group represented by R 13 include an ethynyl group, a 1-propynyl group, a 2-propynyl group and a 3-butynyl group.
  • Examples of the C 2 -C 5 alkoxycarbonyl group represented by R 13 include a methoxycarbonyl group, an ethoxycarbonyl group and a 1-methylethoxycarbonyl group.
  • Examples of the group represented by CR 11 R 12 R 13 include a 1-methylethyl group, a 1-methylpropyl group, a 1-methylbutyl group, a 1-methylpropyl group, a 1,1-diemethylethyl group, a 1,1-dimethylpropyl group, a 1,2-dimethylpropyl group, a 1,2-dimethylbutyl group, a 1,1,2-trimethylpropyl group, a 1,2,2-trimethylpropyl group, a 1,1,2,2-tetramethylpropyl group and a 1-cyano-1,2-dimethylpropyl group.
  • C 3 -C 6 cycloalkyl group optionally substituted with at least one group selected from the group consisting of a C 1 -C 4 alkyl group, a C 2 -C 4 alkenyl group, a C 2 -C 4 alkynyl group, a halogen atom, a hydroxyl group, a cyano group, a carboxyl group and a C 2 -C 5 alkoxycarbonyl group which is represented by Cy;
  • examples of the C 1 -C 4 alkyl group as a substituent include a methyl group, an ethyl group, a propyl group and an isopropyl group,
  • examples of the C 2 -C 4 alkenyl group as a substituent include a vinyl group, a 1-propenyl group, a 2-propenyl group, a 2-butenyl group and a 3-butenyl group
  • Examples of the C 3 -C 6 cycloalkyl in the C 3 -C 6 cycloalkyl group optionally substitute with at least one group selected from the group consisting of a C 1 -C 4 alkyl group, a C 2 -C 4 alkenyl group, a C 2 -C 4 alkynyl group, a chlorine atom, a hydroxyl group, a cyano group, a carboxyl group and a C 2 -C 5 alkoxycarbonyl group which is represented by Cy include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, and a cyclohexyl group.
  • Examples of the group represented by A 2 -Cy specifically include the following groups:
  • a cyclopropylmethyl group a (1-methylcyclopropyl)methyl group, a (2-methylcyclopropyl)methyl group, a (1-hydroxycyclopropyl)methyl group, a (2-hydroxycyclopropyl)methyl group, a 2,2,3,3-tetramethylcyclopropyl)methyl group, a (1-fluorocyclopropyl)methyl group, a (1-chlorocyclopropyl)methyl group, a (1-cyanocyclopropyl)methyl group, a (1-ethoxycarbonylcyclopropyl)methyl group, a (1-methoxycarbonylcyclopropyl)methyl group; a cyclobutylmethyl group, a (1-methylcyclobutyl)methyl group, a (2-methylcyclobutyl)methyl group, a (3-methylcyclobutyl)methyl group, a (1-hydroxycyclobutyl)methyl group, a (2-hydroxycyclobutyl)methyl group, a
  • a 1-(cyclopropyl)ethyl group a 1-(1-methylcyclopropyl)ethyl group, a 1-(2-methylcyclopropyl)ethyl group, a 1-(1-hydroxycyclopropyl)ethyl group, a 1-(2-hydroxycyclopropyl)ethyl group, a 1-(2,2,3,3-tetramethylcyclopropyl)ethyl group, a 1-(1-fluorocyclopropyl)ethyl group, a 1-(1-chlorocyclopropyl)ethyl group, a 1-(1-cyanocyclopropyl)ethyl group, a 1-(1-ethoxycarbonylcylclopropyl)ethyl group, a 1-(1-methoxycarbonylcyclopropyl)ethyl group; a 1-(cyclobutyl)ethyl group, a 1-(1-methylcyolo
  • an amide compound of the formula (1) wherein Z is an oxygen atom, X 1 is a methoxy group, and X 2 is a chlorine atom; an amide compound of the formula (1), wherein Z is an oxygen atom, X 1 is a methoxy group, and X 2 is a bromine atom; an amide compound of the formula (1), wherein Z is an oxygen atom, X 1 is a methoxy group, and X 2 is an iodine atom; an amide compound of the formula (1), wherein Z is an oxygen atom, X 1 is a methoxy group, and X 2 is a C 1 -C 4 alkyl group; an amide compound of the formula (1), wherein Z is an oxygen atom, X 1 is a methoxy group, and X 2 is a C 2 -C 4 alkenyl group; an amide compound of the formula (1), wherein Z is an oxygen atom, X 1 is a methoxy group, and X 2 is a
  • an amide compound of the formula (1), wherein Z is an oxygen atom; an amide compound of the formula (1), wherein X 1 is a fluorine atom; an amide compound of the formula (1), wherein X 1 is a methoxy group; an amide compound of the formula (1), wherein Z is an oxygen atom, and X 1 is a fluorine atom; an amide compound of the formula (1), wherein Z is an oxygen atom, and X 1 is a methoxy group; an amide compound of the formula (1), wherein X 2 is a chlorine atom, a bromine atom or a C 1 -C 4 alkyl group; an amide compound of the formula (1), wherein X 2 is a chlorine atom or a C 1 -C 4 alkyl group; an amide compound of the formula (1), wherein X 2 is a chlorine atom; an amide compound of the formula (1), wherein X 2 is a C 1 -C 4 alkyl group; an amide compound of the
  • an amide compound of the formula (1) wherein A is A 1 -CR 11 R 12 R 13 ; an amide compound of the formula (1), wherein A is A 1 -CR 11 R 12 R 13 , R 11 is a methyl group or an ethyl group, and R 12 is a methyl group, an ethyl group, a 1-methylethyl group, a 1,1-dimethylethyl group or a 1-methylpropyl group; an amide compound of the formula (1), wherein A is A 1 -CR 11 R 12 R 13 , and R 13 is a hydrogen atom or a methyl group; an amide compound of the formula (1), wherein A is A 1 -CR 11 R 12 R 13 , A 1 is a single bond, R 11 is a methyl group, R 12 is a 1-methylethyl group or a 1,1-dimethylethyl group, and R 13 is a hydrogen atom; an amide compound of the formula (1), wherein A is A 2 -
  • an amide compound of the formula (1) wherein A is A 2 -Cy, and Cy is a C 3 -C 6 cycloalkyl group optionally substituted with at least one group selected from the group consisting of a C 1 -C 4 alkyl group, a halogen atom, a hydroxyl group and a cyano group; an amide compound of the formula (1), wherein A is A 2 -Cy, and Cy is a cyclopropyl group optionally substituted with at least one group selected from the group consisting of a C 1 -C 4 alkyl group, a halogen atom, a hydroxyl group and a cyano group; an amide compound of the formula (1), wherein A is A 2 -Cy, and Cy is a cyclobutyl group optionally substituted with at least one group selected from the group consisting of a C 1 -C 4 alkyl group, a halogen atom, a hydroxyl group and a cyano group;
  • an amide compound of the formula (1) wherein A is A 2 -Cy, A 2 is a single bond, and Cy is a cyclohexyl group optionally substituted with at least one group selected from the group consisting of a methyl group, a halogen atom and a hydroxyl group; an amide compound of the formula (1), wherein A is A 2 -Cy, A 2 is a CH 2 group, and Cy is a cyclohexyl group optionally substituted with at least one group selected from the group consisting of a methyl group, a halogen atom and a hydroxyl group; an amide compound of the formula (1), wherein A is A 2 -Cy, A 2 is a CH(CH 3 ) group, and Cy is a cyclohexyl group optionally substituted with at least one group selected from the group consisting of a methyl group, a halogen atom and a hydroxyl group; an amide compound of the formula (1), wherein A is A 2
  • an amide compound of the formula (1) wherein A is A 2 -Cy, and Cy is a C 4 -C 6 cycloalkyl group optionally substituted with a methyl group; an amide compound of the formula (1), wherein A is A 2 -Cy, and Cy is a C 4 -C 6 cycloalkyl group optionally substituted with a halogen atom; an amide compound of the formula (1), wherein A is A 2 -Cy, and Cy is a C 4 -C 6 cycloalkyl group optionally substituted with a fluorine atom; an amide compound of the formula (1), wherein A is A 2 -Cy, and Cy is a C 4 -C 6 cycloalkyl group optionally substituted with a chlorine atom; an amide compound of the formula (1), wherein A is A 2 -Cy, and Cy is a C 4 -C 6 cycloalkyl group optionally substituted with a hydroxyl group; an amide compound of
  • an amide compound of the formula (1) wherein X 2 is a chlorine atom or a C 1 -C 4 alkyl group, and A is A 2 -Cy; an amide compound of the formula (1), wherein X 2 is a chlorine atom or a C 1 -C 4 alkyl group, A is A 2 -Cy, and A 2 is a single bond or a CH 2 group; an amide compound of the formula (1), wherein X 2 is a chlorine atom or a C 1 -C 4 alkyl group, A is A 2 -Cy, A 2 is a single bond or a CH 2 group, and Cy is a C 3 -C 6 cycloalkyl group optionally substituted with at least one group selected from the group consisting of a C 1 -C 4 alkyl group and a hydroxyl group; an amide compound of the formula (1), wherein X 2 is a chlorine atom or a C 1 -C 4 alkyl group, A is A 2 -Cy
  • a structural formula of a compound may conveniently represent a specific isomer.
  • the present invention includes all active isomers such as geometrical isomers, optical isomers, steric isomers and tautomers which may be generated due to the structure of a compound, and a mixture of isomers.
  • a compound is not limited to the description of a specific formula conveniently described and may be any one of isomers or a mixture of isomers. Therefore, in the present invention, a compound may have an asymmetric carbon atom in its molecule and thus may exist as an optically active form or a racemate. In the present invention, there is no limitation, and all cases are included.
  • the compound of the present invention can be produced, for example, by the following Production process 1 to Production process 7.
  • a compound (5) of the present invention in which Z is an oxygen atom can be produced by reacting a compound (2) and a compound (3) in the presence of a dehydration condensing agent.
  • A, X 1 and X 2 are as defined above. The reaction is usually performed in the presence of a solvent.
  • ethers such as tetrahydrofuran (hereinafter, referred to as THF in some cases), ethylene glycol dimethyl ether and tert-butyl methyl ether (hereinafter, referred to as MTBE in some cases), aliphatic hydrocarbons such as hexane, heptane and octane, aromatic hydrocarbons such as toluene and xylene, halogenated hydrocarbons such as chlorobenzene, esters such as butyl acetate and ethyl acetate, nitriles such as acetonitrile, acid amides such as N,N-dimethylformamide (hereinafter, referred to as DMF in some cases), sulfoxides such as dimethyl sulfoxide (hereinafter, referred to as DMSO in some cases), and a mixture thereof.
  • THF tetrahydrofuran
  • MTBE tert-butyl methyl ether
  • Examples of the dehydration condensing agent used in the reaction include carbodiimides such as 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (hereinafter, referred to as WSC) and 1,3-dicyclohexylcarbodiimide.
  • the used amount of the compound (3) is usually 1 to 3 mol per 1 mol of the compound (2).
  • the used amount of the dehydration condensing agent is usually 1 to 5 mol per 1 mol of the compound (2).
  • the reaction temperature is usually in a range of from 0 to 140°C, and the reaction time is usually in a range of from 1 to 24 hours.
  • the compound (5) of the present invention can be isolated by post-treatment such as filtration of the reaction mixture, extraction of the filtrate with an organic solvent, and drying and concentration of an organic layer.
  • the isolated compound (5) of the present invention can be further purified by chromatography, recrystallization or the like.
  • a compound (5) of the present invention in which Z is an oxygen atom can be produced by reacting a compound (2) and a compound (4) in the presence of a base.
  • A, X 1 and X 2 are as defined above. The reaction is usually performed in the presence of a solvent.
  • solvent used in the reaction examples include ethers such as THF, ethylene glycol dimethyl ether and MTBE, aliphatic hydrocarbons such as hexane, heptane and octane, aromatic hydrocarbons such as toluene and xylene, halogenated hydrocarbons such as chlorobenzene, esters such as butyl acetate and ethyl acetate, nitriles such as acetonitriles, acid amides such as DMF, sulfoxides such as DMSO, and a mixture thereof.
  • ethers such as THF, ethylene glycol dimethyl ether and MTBE
  • aliphatic hydrocarbons such as hexane, heptane and octane
  • aromatic hydrocarbons such as toluene and xylene
  • halogenated hydrocarbons such as chlorobenzene
  • esters such as butyl acetate and ethyl a
  • Examples of the base used in the reaction include alkali metal carbonates such as sodium carbonate and potassium carbonate, tertiary amines such as triethyl amine and diisopropylethylamine, and nitrogen-containing aromatic compounds such as pyridine and 4-dimethylaminopyridine.
  • the used amount of the compound (4) is usually 1 to 3 mol per 1 mol of the compound (2).
  • the used amount of the base is usually 1 to 10 mol per 1 mol of the compound (2).
  • the reaction temperature is usually in a range of from -20 to 100°C, and the reaction time is usually in a range of from 0.1 to 24 hours.
  • the compound (5) of the present invention can be isolated by post-treatment such as filtration of the reaction mixture, extraction of the filtrate with an organic solvent, and drying and concentration of an organic layer.
  • the isolated compound (5) of the present invention can be further purified by chromatography, recrystallization or the like.
  • a compound (6) of the present invention in which Z is a sulfur atom can be produced by reacting the compound (5) of the present invention in which Z is an oxygen atom and 2,4-bis(4-methoxyphenyl)-1,3-dithia-2,4-diphosphethane-2,4-disulfide (hereinafter, referred to as Lawesson's reagent).
  • Z is an oxygen atom
  • Lawesson's reagent 2,4-bis(4-methoxyphenyl)-1,3-dithia-2,4-diphosphethane-2,4-disulfide
  • A, X 1 and X 2 are as defined above.
  • the reaction is usually performed in the presence of a solvent.
  • Examples of the solvent used in the reaction include ethers such as THF, ethylene glycol dimethyl ether and MTBE, aliphatic hydrocarbons such as hexane, heptane and octane, aromatic hydrocarbons such as toluene and xylene, halogenated hydrocarbons such as chlorobenzene, organic nitriles such as acetonitrile and butyronitrile, sulfoxides such as dimethyl sulfoxide, and a mixture thereof.
  • the used amount of the Lawesson's reagent is usually 1 to 2 mol per 1 mol of the compound (5) of the present invention.
  • the reaction temperature is usually in a range of from 25 to 150°C
  • the reaction time is a usually in a range of from 0.1 to 24 hours.
  • the compound (6) of the present invention can be isolated by post-treatment such as extraction of the reaction mixture with an organic solvent, and drying and concentration of an organic layer.
  • the isolated compound (6) of the present invention can be further purified by chromatography, recrystallization or the like.
  • a compound (9) of the present invention in which Z is an oxygen atom and X 1 is a fluorine atom can be produced by reacting a compound (7) and a compound (2) in the presence of a base to obtain a compound (8) (step (IV-1)) and then reacting the compound (8) and propargyl alcohol in the presence of a base (step (IV-2)).
  • a and X 2 are as defined above.
  • the reaction is usually performed in the presence of a solvent.
  • a solvent examples include ethers such as THF, ethylene glycol dimethyl ether and MTBE, aliphatic hydrocarbons such as hexane, heptane and octane, aromatic hydrocarbons such as toluene and xylene, halogenated hydrocarbons such as chlorobenzene, esters such as butyl acetate and ethyl acetate, nitriles such as acetonitrile, acid amides such as DMF, sulfoxides such as dimethyl sulfoxide, and a mixture thereof.
  • ethers such as THF, ethylene glycol dimethyl ether and MTBE
  • aliphatic hydrocarbons such as hexane, heptane and octane
  • aromatic hydrocarbons such as toluene and xylene
  • halogenated hydrocarbons such as chlorobenzene
  • esters
  • Examples of the base used in the reaction include alkali metal carbonates such as sodium carbonate and potassium carbonate, tertiary amines such as triethylamine and diisopropylethylamine, and nitrogen-containing aromatic compounds such as pyridine and 4-dimethylaminopyridine.
  • the used amount of the compound (7) is usually 1 to 3 mol per 1 mol of the compound (2).
  • the used amount of the base usually 1 to 10 mol per 1 mol of the compound (2).
  • the reaction temperature is usually in a range of from -20 to 100°C, and the reaction time is usually in a range of from 0.1 to 24 hours.
  • the compound (8) can be isolated by post-treatment such as extraction of the reaction mixture with an organic solvent, and drying and concentration of an organic layer. The isolated compound (8) can be further purified by chromatography, recrystallization or the like.
  • the reaction is usually performed in the presence of a solvent.
  • a solvent examples include ethers such as THF, ethylene glycol dimethyl ether and MTBE, aliphatic hydrocarbons such as hexane, heptane and octane, ketones such as acetone, methyl ethyl ketone and methyl isobutyl ketone, aromatic hydrocarbons such as toluene and xylene, halogenated hydrocarbons such as chlorobenzene, esters such as butyl acetate and ethyl acetate, nitriles such as acetonitrile, acid amides such as DMF, sulfoxides such as dimethyl sulfoxide, and a mixture thereof.
  • ethers such as THF, ethylene glycol dimethyl ether and MTBE
  • aliphatic hydrocarbons such as hexane, heptane and octane
  • ketones such as ace
  • Examples of the base used in the reaction include alkali metal carbonates such as sodium carbonate and potassium carbonate, alkali metal hydrogen carbonates such as sodium hydrogen carbonate, alkali metal hydrides such as sodium hydride, and alkali metal hydroxides such as sodium hydroxide.
  • the used amount of propargyl alcohol is usually 1 to 3 mol per 1 mol of the compound (8).
  • the used amount of the base is usually 1 to 2 mol per 1 mol of the compound (8).
  • the reaction temperature is usually in a range of from -20 to 100°C, and the reaction time is usually in a range of from 0.1 to 24 hours.
  • the compound (9) of the present invention can be isolated by post-treatment such as extraction of the reaction mixture with an organic solvent, and drying and concentration of an organic layer.
  • the isolated compound (9) of the present invention can be further purified by chromatography, recrystallization or the like.
  • a compound (5) of the present invention in which Z is an oxygen atom can be produced by reacting a compound (10) and propargyl bromide in the presence of a base.
  • A, X 1 and X 2 are as defined above. The reaction is usually performed in the presence of a solvent.
  • solvent used in the reaction examples include ethers such as THF, ethylene glycol dimethyl ether and MTBE, aromatic hydrocarbons such as toluene and xylene, halogenated hydrocarbons such as chlorobenzene, nitriles such as acetonitrile, acid amides such as DMF, sulfoxides such as dimethyl sulfoxide, ketones such as acetone, methyl ethyl ketone and methyl isobutyl ketone, water, and a mixture thereof.
  • ethers such as THF, ethylene glycol dimethyl ether and MTBE
  • aromatic hydrocarbons such as toluene and xylene
  • halogenated hydrocarbons such as chlorobenzene
  • nitriles such as acetonitrile
  • acid amides such as DMF
  • sulfoxides such as dimethyl sulfoxide
  • ketones such as acetone, methyl ethyl ketone and
  • Examples of the base used in the reaction include alkali metal carbonates such as sodium carbonate, potassium carbonate and cesium carbonate, alkali metal hydroxides such as sodium hydroxide, and alkali metal hydrides such as sodium hydride.
  • the used amount of propargyl bromide is usually 1 to 3 mol per 1 mol of the compound (10).
  • the used amount of the base is usually 1 to 3 mol per 1 mol of the compound (10).
  • the reaction temperature is usually in a range of from -20 to 100°C, and the reaction time is usually in a range of from 0.1 to 24 hours.
  • the compound (5) of the present invention can be isolated by post-treatment such as extraction of the reaction mixture with an organic solvent, and drying and concentration of an organic layer.
  • the isolated compound (5) of the present invention can be further purified by chromatography, recrystallization or the like.
  • a compound (12) of the present invention in which Z is an oxygen atom, A is A 2 -Cy, A 2 is a single bond, and Cy is a 2-fluorocyclohexyl group, a 2-chlorocyclohexyl group, a 2-bromocyclohexyl group, a 2-iodocyclohexyl group or a 2-cyanocyclohexyl group can be produced by a process shown in the following scheme.
  • a compound (12) of the present invention in which R 14 is a chlorine atom can be produced by reacting a compound (4) and 7-azabicyclo[4.1.0]heptane without isolation of an intermediate (11).
  • X 1 and X 2 are as defined above, and R 14 represents a fluorine atom, a chlorine atom, a bromine atom, an iodine atom or a cyano group.
  • the compound (11) can be produced by reacting the compound (4) and 7-azabicyclo[4.1.0]heptane in the presence of a base according to the process described in Production process 2.
  • the compound (12) of the present invention can be produced by reacting the compound (11) and the following reagent.
  • the reagent used in the reaction include alkali metal fluorides such as potassium fluoride and lithium fluoride, alkaline earth metal fluorides such as calcium fluoride, quaternary ammonium fluorides such as tetrabutylammonium fluoride, and hydrogen fluoride.
  • alkali metal chlorides such as sodium chloride and lithium chloride
  • alkaline earth metal chlorides such as magnesium chloride
  • metal chlorides such as aluminum chloride and zinc(II) chloride
  • quaternary ammonium chlorides such as tetrabutylammonium chloride
  • organic silicon chlorides such as trimethylsilyl chloride
  • Examples of the reagent used in the reaction, in the case where R 14 in the compound (12) is a bromine atom, include alkali metal bromides such as sodium bromide, alkaline earth metal bromides such as magnesium bromide, metal bromides such as zinc(II) bromide, quaternary ammonium bromides such as tetrabutylammonium bromide, organic silicon bromides such as trimethylsilyl bromide, phosphorus compounds such as phosphorus tribromide, and hydrogen bromide.
  • Examples of the reagent used in the reaction, in the case where R 14 in the compound (12) is an iodine atom, include alkali metal iodides such as potassium iodide, alkaline earth metal iodides such as magnesium iodide, metal iodides such as zinc(II) iodide, quaternary ammonium iodides such as tetrabutylammonium iodide, organic silicon compounds such as trimethylsilyl iodide, and hydrogen iodide.
  • alkali metal iodides such as potassium iodide
  • alkaline earth metal iodides such as magnesium iodide
  • metal iodides such as zinc(II) iodide
  • quaternary ammonium iodides such as tetrabutylammonium iodide
  • organic silicon compounds such as trimethylsilyl iodide
  • Examples of the reagent used in the reaction include cyanides such as potassium cyanide and sodium cyanide, and organic silicon compounds such as trimethylsilyl cyanide.
  • the reaction is usually performed in the presence of a solvent.
  • the solvent used in the reaction include ethers such as THF, ethylene glycol dimethyl ether and MTBE, aromatic hydrocarbons such as toluene and xylene, halogenated hydrocarbons such as chlorobenzene and chloroform, esters such as butyl acetate and ethyl acetate, nitriles such as acetonitrile, acid amides such as DMF, water, and a mixture thereof.
  • the used amount of the reagent is usually 1 to 10 mol per 1 mol of the compound (11).
  • the reaction temperature is usually in a range of from -20 to 150°C, and the reaction time is usually in a range of from 0.1 to 24 hours.
  • the compound (12) of the present invention can be isolated by post-treatment such as extraction of the reaction mixture with an organic solvent, and drying and concentration of an organic layer.
  • the isolated compound (12) of the present invention can be further purified by chromatography, recrystallization or the like.
  • X 1 and X 2 are as defined above, A 3 is A 2 -Cy and Cy represents a C 3 -C 6 cycloalkyl group substituted with at least one hydroxyl group, and A 4 is A 2 -Cy and Cy represents a C 3 -C 6 cycloalkyl group substituted with at least one halogen atom.
  • the compound (14) of the present invention may be produced by reacting the compound (13) and the following halogenating reagent.
  • Examples of the halogenating reagent used in the reaction in the case where the halogen atom of the C 3 -C 6 cycloalkyl group substituted with at least one halogen atom in the compound (14) of the present invention is a fluorine atom, include fluorinating agents such as 2,2-difluoro-1,3-dimethylimidazolidine, hydrogen fluoride pyridine complex, diethyl(1,2,3,3,3-pentafluoro-1-propenyl)amine, di(2-methoxyethyl)sulfur trifluoride, diethylaminosulfur trifluoride, tetrafluorosulfur and N-(2-chloro-1,1,2-trifluoroethyl)diethylamine.
  • fluorinating agents such as 2,2-difluoro-1,3-dimethylimidazolidine, hydrogen fluoride pyridine complex, diethyl(1,2,3,3,3-pentafluoro
  • Examples of the halogenating reagent used in the reaction in the case where the halogen atom of the C 3 -C 6 cycloalkyl group substituted with at least one halogen atom in the compound (14) of the present invention is a chlorine atom, include chlorinating agents such as thionyl chloride, phosphorus oxychloride, phosphorus trichloride, phosphorus pentachloride and phosgene.
  • Examples of the halogenating reagent used in the reaction in the case where the halogen atom of the C 3 -C 6 cycloalkyl group substituted with at least one halogen atom in the compound (14) of the present invention is a bromine atom, include brominating agents such as phosphorus tribromide.
  • Examples of a solvent used in the reaction include ethers such as THF, ethylene glycol dimethyl ether and MTBE, aromatic hydrocarbons such as toluene and xylene, halogenated hydrocarbons such as chlorobenzene and chloroform, nitriles such as acetonitrile, and a mixture thereof.
  • the used amount of the reagent is usually 1 to 10 mol per 1 mol of the compound (13) of the present invention.
  • the reaction temperature is usually in a range of from -78 to 150°C, and the reaction time is usually in a range of from 0.1 to 24 hours.
  • the compound (14) of the present invention can be isolated by post-treatment such as extraction of the reaction mixture with an organic solvent, and drying and concentration of an organic layer.
  • the isolated compound (14) of the present invention can be further purified by chromatography, recrystallization or the like.
  • the compound (3) and the compound (4) can be produced by the process shown in the following scheme.
  • X 1 and X 2 are as defined above.
  • the compound (M2) can be produced by reacting the compound (M1) and propargyl bromide in the presence of a base.
  • the reaction is usually performed in the presence of a solvent.
  • the solvent used in the reaction include acid amides such as DMF and sulfoxides such as DMSO.
  • Examples of the base used in the reaction include alkali metal carbonates such as sodium carbonate, potassium carbonate and cesium carbonate, and alkali metal hydroxides such as sodium hydroxide.
  • the used amount of propargyl bromide is usually 2 to 5 mol per 1 mol of the compound (M1).
  • the used amount of the base is usually 2 to 5 mol per 1 mol of the compound (M1).
  • the reaction temperature is usually in a range of from 0 to 140°C, and the reaction time is usually in a range of from 0.5 to 24 hours.
  • the compound (M2) can be isolated by post-treatment such as extraction of the reaction mixture with an organic solvent, and drying and concentration of an organic layer.
  • the isolated compound (M2) can be further purified by chromatography, recrystallization or the like.
  • the compound (3) can be produced by hydrolyzing the compound (M2) in the presence of a base.
  • the reaction is usually performed in the presence of a solvent.
  • the base used in the reaction include alkali metal hydroxides such as sodium hydroxide and potassium hydroxide.
  • the solvent used in the reaction include ethers such as tetrahydrofuran, ethylene glycol dimethyl ether and tert-butyl methyl ether, alcohols such as methanol and ethanol, water, and a mixture thereof.
  • the used amount of the base is usually 1 to 10 mol per 1 mol of the compound (M2).
  • the reaction temperature is usually in a range of from 0 to 120°C
  • the reaction time is usually in a range of from 0.5 to 24 hours.
  • the reaction solution is made acidic.
  • the compound (3) can be isolated by filtration.
  • the compound (3) can be isolated by post-treatment such as extraction of the reaction mixture with an organic solvent, and drying and concentration of an organic layer.
  • the isolated compound (3) can be further purified by chromatography, recrystallization or the like.
  • the compound (4) can be produced by reacting the compound (3) and thionyl chloride.
  • the reaction is usually performed in the presence of a solvent.
  • the solvent used in the reaction include aliphatic hydrocarbons such as hexane, heptane and octane, aromatic hydrocarbons such as toluene and xylene, nitriles such as acetonitrile, halogenated hydrocarbons such as chlorobenzene, acid amides such as DMF, and a mixture thereof.
  • the used amount of thionyl chloride is usually 1 to 2 mol per 1 mol of the compound (3).
  • the reaction temperature is usually in a range of from 20 to 120°C, and the reaction time is usually in a range of from 0.1 to 24 hours.
  • the compound (4) can be isolated by post-treatment such as concentration of the reaction mixture.
  • the isolated compound (4) can be further purified by chromatography, recrystallization or the like.
  • the compound (10) can be produced by the process shown in the following scheme.
  • A, X 1 and X 2 are as defined above.
  • the compound (M3) can be produced by reacting the compound (M1) and benzyl bromide in the presence of a base.
  • the reaction is usually performed in the presence of a solvent.
  • the solvent used in the reaction include acid amides such as DMF, and sulfoxides such as DMSO.
  • Examples of the base used in the reaction include alkali metal carbonates such as sodium carbonate, potassium carbonate and cesium carbonate, and alkali metal hydroxides such as sodium hydroxide.
  • the used amount of benzyl bromide is usually 2 to 5 mol per 1 mol of the compound (M1).
  • the used amount of the base is usually 2 to 5 mol per 1 mol of the compound (M1)
  • the reaction temperature is usually in a range of from 0 to 140°C
  • the reaction time is usually in a range of from 0.5 to 24 hours.
  • the compound (M3) can be isolated by post-treatment such as extraction of the reaction mixture with an organic solvent, and drying and concentration of an organic layer.
  • the isolated compound (M3) can be further purified by chromatography, recrystallization or the like.
  • the compound (M4) can be produced by hydrolyzing the compound (M3) in the presence of a base.
  • the reaction is usually performed in the presence of a solvent.
  • the base used in the reaction include alkali metal hydroxides such as sodium hydroxide and potassium hydroxide.
  • the solvent used in the reaction include ethers such as tetrahydrofuran, ethylene glycol dimethyl ether and MTBE, alcohols such as methanol and ethanol, water, and a mixture thereof.
  • the used amount of the base is usually 1 to 10 mol per 1 mol of the compound (M3).
  • the reaction temperature is usually in a range of from 0 to 120°C, and the reaction time is usually in a range of from 0.5 to 24 hours.
  • the reaction solution is made acidic.
  • the compound (M4) can be isolated by filtration.
  • the compound (M4) can be isolated by post-treatment such as extraction of the reaction mixture with an organic solvent, and drying and concentration of an organic layer.
  • the isolated compound (M4) can be further purified by chromatography, recrystallization of the like.
  • the compound (M5) can be produced by reacting the compound (M4) and thionyl chloride.
  • the reaction is usually performed in the presence of a solvent.
  • the solvent used in the reaction include aliphatic hydrocarbons such as hexane, heptane and octane, aromatic hydrocarbons such as toluene and xylene, nitriles such as acetonitrile, halogenated hydrocarbons such as chlorobenzene, acid amides such as DMF, and a mixture thereof.
  • the used amount of thionyl chloride is usually 1 to 2 mol per 1 mol of the compound (M4).
  • the reaction temperature is usually in a range of from 20 to 120°C, and the reaction time is usually in a range of from 0.1 to 24 hours.
  • the compound (M5) can be isolated by post-treatment such as concentration of the reaction mixture.
  • the isolated compound (M5) can be further purified by chromatography, recrystallization or the like.
  • the compound (M6) can be produced by reacting the compound (M5) and the compound (2) in the presence of a base according to the process described in Production process 2.
  • the compound (10) can be produced by reacting the compound (M6) with hydrogen in the presence of palladium carbon.
  • the reaction is usually performed in the presence of a solvent.
  • the solvent used in the reaction include aliphatic hydrocarbons such as hexane, heptane and octane, aromatic hydrocarbons such as toluene and xylene, alcohols such as methanol and ethanol, esters such as ethyl acetate, ethers such as THF and MTBE, water, and a mixture thereof.
  • the used amount of palladium carbon is 0.01 to 0.1 mol per 1 mol of the compound (M6).
  • the used amount of hydrogen is usually 1 to 2 mol per 1 mol of the compound (M6).
  • the reaction temperature is usually in a range of from 0 to 50°C, and the reaction time is usually in a range of from 0.1 to 24 hours.
  • the pressure of hydrogen used in the reaction is in a range of from normal pressure to 10 atoms.
  • Examples of a compound represented by the formula (3): wherein X 1 , and X 2 are as defined above, which is an intermediate for producing the compound of the present invention include the following compounds:
  • Examples of a compound represented by the formula (10) : wherein X 1 , X 2 and A are as defined above, which is an intermediate for producing the compound of the present invention include the following compounds:
  • Examples of a compound represented by the formula (11) : wherein X 1 and X 2 are as defined above, which is an intermediate for producing the compound of the present invention include the following compounds:
  • Plant diseases against which the compound of the present invention exerts an excellent effect include those caused by fungi, bacteria and viruses.
  • the fungi include genus Erysiphe such as wheat powdery mildew ( Erysiphe graminis ), genus Uncinula such as grape powdery mildew ( Uncinula necator ), genus Podosphaera such as apple powdery mildew ( Podosphaera leucotricha ), genus Sphaerotheca such as cucumber powdery mildew ( Sphaerotheca cucurbitae ), genus oidiopsis such as tomato powdery mildew ( Oidiopsis sicula ), genus Magnaporthe such as rice blast ( Magnaporthe oryzae ), genus Cachliobolus such as rice brown spot ( Cochliobolus miyabeanus ), genus Mycosphaerella such as wheat leaf blotch ( Mycos
  • bacteria examples include genus Burkholderia such as bacterial rice seedling blight ( Burkholderia plantarii ), genus Pseudomanas such as bacterial cucumber leaf spot ( Pseudomonas syringae pv. Lachrymans ), genus Ralstonia such as eggplant wilting ( Ralstonia solanacearum ), genus Xanthomonas such as Asiatic citrus canker ( Xanthomonas citiri ), and genus Erwinia such as Chinese cabbage bacterial soft rot ( Erwinia carotovora ).
  • viruses include Tobacco mosaic virus and Cucumber mosaic virus. However, the sterilizing spectra should not be limited thereto in any cases.
  • the plant disease controlling agent of the present invention can be the compound of the present invention itself, but usually it is used in the form of formulations such as emulsifiable concentrates, wettable powders, granular wettable powders, flowable formulations, dusts, and granules produced by mixing it with solid carriers, liquid carriers, surface active agents and other auxiliary agents for formulation. These formulations usually contain the compound of the present invention in an amount of 0.1 to 90 % by weight.
  • solid carriers used in the formulations include fine powders or particles of minerals such as kaolin clay, attapulgite clay, bentonite, montmorillonite, acid clay, pyrophyllite, talc, diatomaceous earth, and calcite; natural organic substances such as corncob powder, and walnut shell flour; synthetic organic substances such as urea; salts such as calcium carbonate, and ammonium sulfate; and synthetic inorganic substances such as synthetic hydrated silicon oxide.
  • minerals such as kaolin clay, attapulgite clay, bentonite, montmorillonite, acid clay, pyrophyllite, talc, diatomaceous earth, and calcite
  • natural organic substances such as corncob powder, and walnut shell flour
  • synthetic organic substances such as urea
  • salts such as calcium carbonate, and ammonium sulfate
  • synthetic inorganic substances such as synthetic hydrated silicon oxide.
  • liquid carriers examples include aromatic hydrocarbons such as xylene, alkylbenzene and methylnaphthalene; alcohols such as 2-propanol, ethylene glycol, propylene glycol and cellosolve; ketones such as acetone, cyclohexanone and isophorone; vegetable oils such as soybean oil and cottonseed oil; petroleum aliphatic hydrocarbons; esters; and dimethyl sulfoxide, acetonitrile and water.
  • aromatic hydrocarbons such as xylene, alkylbenzene and methylnaphthalene
  • alcohols such as 2-propanol, ethylene glycol, propylene glycol and cellosolve
  • ketones such as acetone, cyclohexanone and isophorone
  • vegetable oils such as soybean oil and cottonseed oil
  • petroleum aliphatic hydrocarbons such as soybean oil and cottonseed oil
  • esters and dimethyl sulfoxide, acetonitrile and water.
  • surfactant examples include anionic surfactants such as alkyl sulfate, alkyl aryl sulfonate, dialkyl sulfosuccinate, polyoxyethylene alkyl aryl ether phosphate, ligninsulfonate and a naphthalenesulfonate formaldehyde polycondensate; and nonionic surfactants such as polyoxyethylene alkyl aryl ether, a polyoxyethylene alkyl polyoxypropylene block copolymer and sorbitan fatty acid ester.
  • anionic surfactants such as alkyl sulfate, alkyl aryl sulfonate, dialkyl sulfosuccinate, polyoxyethylene alkyl aryl ether phosphate, ligninsulfonate and a naphthalenesulfonate formaldehyde polycondensate
  • nonionic surfactants such as polyoxyethylene alkyl aryl ether,
  • auxiliary agent for formulation examples include water-soluble polymers such as polyvinyl alcohol and polyvinyl pyrrolidone; polysaccharides such as gum Arabic, alginic acid and a salt thereof, CMC (carboxymethyl cellulose) and xanthan gum; inorganic substances such as aluminum magnesium silicate, and alumina sol; preservatives; colorants; PAP (acidic isopropyl phosphate); and stabilizers such as BHT.
  • water-soluble polymers such as polyvinyl alcohol and polyvinyl pyrrolidone
  • polysaccharides such as gum Arabic, alginic acid and a salt thereof, CMC (carboxymethyl cellulose) and xanthan gum
  • inorganic substances such as aluminum magnesium silicate, and alumina sol
  • preservatives colorants
  • PAP acidic isopropyl phosphate
  • stabilizers such as BHT.
  • the plant disease controlling agent of the present invention is used for treating plants to protect the plants from plant diseases, and is also used for treating soil to protect plants growing in the soil from plant diseases.
  • the plant disease controlling agent of the present invention When the plant disease controlling agent of the present invention is used by subjecting plants to a foliage treatment used by treating soil, its application amount varies depending upon the kind of crops as plants to be protected, the kind of diseases to be controlled, severity of diseases, form of the formulation, time of application, weather conditions and the like.
  • the total amount of the compound of the present invention is usually within a range of from 1 to 5,000 g, and preferably from 5 to 1,000 g per 10,000 m 2 .
  • Emulsifiable concentrates, wettable powders and flowable formulations are usually used for treatment by spraying after dilution with water.
  • the concentration of the compound of the present invention is usually within a range of from 0.0001 to 3% by weight, and preferably from 0.0005 to 1% by weight. Dusts and granules are usually used for a treatment without being diluted.
  • the plant disease controlling agent of the present invention can be used by a treating method such as seed disinfection.
  • a treating method such as seed disinfection.
  • the method include a method of immersing seeds of plants in the plant disease controlling agent of the present invention in which the concentration of the compound of the present invention is adjusted within a range of 1 to 1,000 ppm, a method of spraying or smearing the plant disease controlling agent of the present invention in which the concentration of the compound of the present invention is adjusted within a range of from 1 to 1,000 ppm, on seeds of plants, and a method of dust coating of seeds of plants using the plant diseases controlling agent of the present invention.
  • the method for controlling a plant disease of the present invention is usually carried out by treating a plant in which onset of diseases is presumed, or soil where the plant is growing, with an effective amount of the plant disease controlling agent of the present invention, and/or treating a plant in which onset of diseases has been confirmed, or the soil where the plants are growing.
  • the plant disease controlling agent of the present invention can be used as a controlling agent for plant diseases in crop lands such as upland fields, paddy fields, lawn, and orchards, etc.
  • the plant disease controlling agent can control plant diseases in crop lands where the following "crops" or the like are cultivated.
  • Field crops corn, rice, wheat, barley, rye, oat, sorghum, cotton, soybean, peanut, buckwheat, beet, rape, sunflower, sugarcane, tobacco, etc.
  • Vegetables solanaceae (e.g. eggplant, tomato, green pepper, pepper and potato), Cucurbitaceae (e.g. cucumber, pumpkin, zucchini, watermelon and melon), Cruciferae (e.g. Japanese radish, turnip, horseradish, kohlrabi, Chinese cabbage, cabbage, leaf mustard, broccoli and cauliflower), Compositae (e.g.
  • crops include crops having resistance to herbicides such as HPPD inhibitors (e.g. isoxaflutole), ALS inhibitors (e.g. imazethapyr and thifensulfuron-methyl), EPSP synthetase inhibitors, glutamine synthetase inhibitors, bromoxynil, etc. which has been imparted by a classic breeding method or a genetic recombination technology.
  • HPPD inhibitors e.g. isoxaflutole
  • ALS inhibitors e.g. imazethapyr and thifensulfuron-methyl
  • EPSP synthetase inhibitors e.g. imazethapyr and thifensulfuron-methyl
  • EPSP synthetase inhibitors e.g. imazethapyr and thifensulfuron-methyl
  • EPSP synthetase inhibitors e.g. imazethapyr and thifensul
  • Examples of the "crops" having the resistance imparted by the classic breeding method include Glearfield® canola resistnt to imidazolinone herbicides (e.g. imazethapyr) and STS soybean resistant to sulfonylurea ALS inhibition type herbicides (e.g. thifensulfuron-methyl).
  • Glearfield® canola resistnt to imidazolinone herbicides e.g. imazethapyr
  • STS soybean resistant to sulfonylurea ALS inhibition type herbicides e.g. thifensulfuron-methyl.
  • crops include crops which have been enabled by the genetic recombination technology to synthesize a selective toxin known in the case of, for example Bacillus.
  • toxin produced in such genetically modified plants include insecticidal proteins derived from Bacillus cereus and Bacillus popilliae; insecticidal proteins such as ⁇ -endotoxins (e.g.
  • the toxin produced in such genetically engineered crops also include hybrid toxins, partly deficient toxins and modified toxins of insecticidal proteins such as 5-endotoxin proteins (e.g. Cry1Ab, Cry1Ac, Cry1F, Cry1Fa2, Cry2Ab, Cry3A, Cry3Bb1 and Cry9C), VIP 1, VIP 2, VIP 3, VIP 3A, etc.
  • the hybrid toxins are produced by a novel combination of the different domains of suchproteins by adoping a recombination technology.
  • the partly deficient toxin Cry1Ab deficient in a part of the amino acid sequence is known.
  • the modified toxins one or more amino acids of a natural toxin have been replaced.
  • Examples of such toxins and genetically modified plants capable of synthesizing such toxins are described in EP-A-0 374 753 , WO 93/07278 , WO 95/34656 , EP-A-0 427 529 , EP-A-451 878 , WO 03/052073 , etc.
  • the toxins contained in such genetically engineered plants impart resistance to insect pests of Coleoptera, insect pests of Diptera and insect pests of Lepidoptera to the plants.
  • Genetically engineered plants containing one or more insecticidal insect-resistance genes and capable of producing one or more toxins have already been known, and some of them are on the market.
  • Examples of such genetically modified plants include YieldGard® (a corn cultivar capable of producing Cry1Ab toxin), YieldGard Rootwarm® (a corn cultivar capable of producing Cry3Bb1 toxin), YieldGard Plus® (a corn cultivar capable of producing Cry1Ab and Cry3Bb1 toxins), Herculex I® (a corn cultivar capable of producing phosphinotrysin N-acetyltransferase (PAT) for imparting resistance to Cry1Fa2 toxin and Glyfosinate), NuCOTN33B (a cotton cultivar capable of producing Cry1Ac toxin), Bollgard I® (a cotton cultivar capable of producing Cry1Ac toxin), Bollgard II® (a cotton cultivar capable of producing Cry1Ac and Cry2Ab
  • crops also include crops having an ability to produce an anti-pathogenic substance having a selective action which has been imparted by a gene recombination technology.
  • anti-pathogenic substance PR proteins and the like are known (PRPs, EP-A-0 392 225 ).
  • PRPs PR proteins and the like are known (PRPs, EP-A-0 392 225 ).
  • Such anti-pathogenic substances and genetically engineered plants capable of producing them are described in EP-A-0 392 225 , WO 95/33818 , EP-A-0 353 191 , and the like.
  • anti-pathogenic substances produced by the genetically modified plants include ion channel inhibitors such as sodium channel inhibitors, calcium channel inhibitors (for example, KP1, KP4 and KP6 toxins produced by viruses are known), etc.; stilbene synthase; bibenzyl synthase; chitinase; glucanase; PR proteins; and anti-pathogenic substances produced by microorganisms such as peptide antibiotics, antibiotics having a heterocyclic ring, protein factors concerned in resistance to plant diseases (which are called plant-disease-resistant genes and are described in WO 03/000906 ), etc.
  • ion channel inhibitors such as sodium channel inhibitors, calcium channel inhibitors (for example, KP1, KP4 and KP6 toxins produced by viruses are known), etc.
  • stilbene synthase such as sodium channel inhibitors, calcium channel inhibitors (for example, KP1, KP4 and KP6 toxins produced by viruses are known), etc.
  • stilbene synthase such as sodium channel
  • plant disease controlling agent of the present invention after mixing with other fungicides, insecticides, acaricides, nematocides, herbicides, plant growth regulators, fertilizers or soil conditioners, or to use the agent without mixing them.
  • Examples of the active ingredients of the plant disease controlling agent include chlorothalonil, fluazinam, dichlofluanid, fosetyl-Al, cyclic imide derivatives (e.g., captan, captafol, folpet, etc.), dithiocarbamate derivatives (e.g., maneb, mancozeb, thiuram, ziram, zineb, propineb, etc.), inorganic or organic copper derivatives (e.g., basic copper sulfate, basic copper chloride, copper hydroxide, oxine-copper, etc.), acylalanine derivatives (e.g., metalaxyl, furalaxyl, ofurace, cyprofuram, benalaxyl, oxadixyl, etc.), strobilurine like compound (e.g., kresoxim-methyl, azoxystrobin, trifloxystrobin, picoxystrobin,
  • N-(2-methylcyclohexyl)-3-chloro-5-fluoro-4-(2-propynyloxy)benzamide (hereinafter, referred to as a compound 2 of the present invention) was obtained according to a process described in Production Example 1 except that 2-methylcyclohexylamine was used in place of cyclohexylmethylamine.
  • N-(2-methylcyclopentyl)-3-chloro-5-fluoro-4-(2-propynyloxy)benzamide (hereinafter, referred to as a compound 3 of the present invention) was obtained according to a process described in Production Example 1, except that 2-methylcyclopentylamine was used in place of cyclohexylmethylamine.
  • N-(1-hydroxycyclohexyl)methyl-3-chloro-5-fluoro-4-(2-propynyloxy)benzamide (hereinafter, referred to as a compound 4 of the present invention) was obtained according to a process described in Production Example 1 except that 1-(1-hydroxycyclohexyl)methylamine hydrochloride was used in place of cyclohexylmethylamine.
  • N-(cyclohexylmethyl)-3-methoxy-5-methyl-4-(2-propynyloxy)benzamide (hereinafter, referred to as a compound 5 of the present invention) was obtained according to a process described in Production Example 1 except that 3-methoxy-5-methyl-4-(2-propynyloxy)benzoyl chloride was used in place of 3-chloro-5-fluoro-4-(2-propynyloxy)benzoyl chloride.
  • N-(2-methylcyclohexyl)-3-methoxy-5-methyl-4-(2-propynyloxy)benzamide (hereinafter, referred to as a compound 6 of the present invention) was obtained according to a process described in Production Example 1 except that 2-methylcyclohexylamine and 3-methoxy-5-methyl-4-(2-propynyloxy)benzoyl chloride were used in place of cyclohexylmethylamine and 3-chloro-5-fluoro-4-(2-propynyloxy)benzoyl chloride respectively.
  • N-(1-hydroxycyclohexyl)methyl-3-methoxy-5-methyl-4-(2-propynyloxy)benzamide (hereinafter, referred to as a compound 7 of the present invention) was obtained according to a process described in Production Example 1 except that 1-(1-hydroxycyclohexyl)methylamine hydrochloride and 3-methoxy-5-methyl-4-(2-propynyloxy)benzoyl chloride were used in place of cyclohexylmethylamine and 3-chloro-5-fluoro-4-(2-propynyloxy)benzoyl chloride respectively.
  • each of the compounds 1 to 8 of the present invention 50 parts of each of the compounds 1 to 8 of the present invention, 3 parts of calcium ligninsulfonate, 2 parts of magnesium laurylsulfate and 45 parts of synthetic hydrated silica are pulverized and mixed well to give a wettable powder of each compound.
  • Test Examples show that the compounds of the present invention are useful for controlling a plant disease.
  • the controlling effect was evaluated by visually observing the area or a lesion spots on each of test plants at the time of investigation and comparing the area of lesion spots on a plant treated with the compound of the present invention with that on an untreated plant.
  • Each of plastic pots was filled with sandy loam and sown with wheat (cultivar; Shiragane), followed by growing in a greenhouse for 10 days.
  • Each of the compounds 2 and 3 of the present invention was formulated into a flowable formulation according to Formulation Example 6.
  • the flowable formulation was diluted to a predetermined concentration (500 ppm) with water, and foliage application of the dilution was carried out so that the dilution adhered sufficiently to the surfaces of leaves of the grown wheat young seedling. After the foliage application, the plant was air-dried and then inoculated by sprinkling with spores of Erysipne graminis f. sp. tritici.
  • the plant was held in a greenhouse at 23°C for 7 days and the area of lesion spots was investigated. As a result, it was found that the area of lesion spots on the plant treated with each of the compounds 2 and 3 of the present invention was 30% or less of that on an untreated plant.
  • Each of plastic pots was filled with sandy loam and sown with wheat (cultivar; Shirogane), followed by growing in a greenhouse for 10 days.
  • Each of the compounds 2 and 3 of the present invention was formulated into a flowable formulation according to Formulation Example 6.
  • the flowable formulation was diluted to a predetermined concentration (500 ppm) with water, and foliage application of the dilution was carried out so that the dilution adhered sufficiently to the surfaces of leaves of the grown wheat young seedling. After the foliage application, the plant was air-dried and then inoculated by spraying a water suspension of spores of Stagonospora nodorum.
  • the plant was held under darkness and high humidity conditions at 18°C for 4 days and held under lighting conditions for 4 days, and thenthe area of lesion spots was investigated. As a result, it was found that the area of lesion spots on the plant treated with each of the compounds 2 or 3 of the present invention was 30% or less of that on an untreated plant.
  • each of plastic pots was filled with sandy loam and sown with wheat (cultivar; Shirogane), followed by growing in a greenhouse for 10 days.
  • the compound 1 of the present invention was formulated into a flowable formulation according to Formulation Example 6.
  • the flowable formulation was diluted to a predetermined concentration (500 ppm) with water, and foliage application of the dilution was carried out so that the dilution adhered sufficiently to the surfaces of leaves of the grown wheat young seedling. After the foliage application, the plant was air-dried and then inoculated by spraying a water suspension of spores of Fusarium culmorum.
  • the plant was held under darkness and high humidity conditions at 23°C for 4 days and held under lighting conditions for 3 days, and then the area of lesion spots was investigated. As a result, it was found that the area of lesion spots on the plant treated with the compound 1 of the present invention was 30% or less of that on an untreated plant.
  • the compound 2 of the present invention was formulated into a flowable formulation according to Formulation Example 6.
  • the flowable formulation was diluted to a predetermined concentration (500 ppm) with water, and foliage application of the dilution was carried out so that the dilution adhered sufficiently to the surfaces of leaves of the grown cucumber young seedling.
  • foliage application the plant was air-dried and a PDA medium containing mycelia of Sclerotinia sclerotiorum was placed on the surfaces of the cucumber leaves.
  • the plant was grown at 18°C and high humidity for 4 days. Then, the area of lesion spots was investigated. As a result, it was found that the area of lesion spots on the plant treated with the compound 2 of the present invention was 30% or less of that on an untreated plant.
  • Each of plastic pots was filled with sandy loam and sown with tomato (cultivar; Patio), followed by growing in a greenhouse for 20 days.
  • Each of the compounds 3, 4 and 7 of the present invention was formulated into a flowable formulation according to Formulation Example 6.
  • the flowable formulation was diluted to a predetermined concentration (500 ppm) with water, and foliage application of the dilution was carried out so that the dilution adhered sufficiently to the surfaces of leaves of the grown tomato young seedling. After the plant was air-dried so that the diluted solution on leaves was dried, a water suspension of zoosporangia of Phytophthora infestans was sprayed.
  • the plant was held under high humidity conditions at 23°C for 1 day and held in a greenhouse for 4 days, and then the area of lesion spots was investigated. As a result, it was found that the area of lesion spots on the plant treated with each of the compounds 3, 4 and 7 of the present invention was 30% or less of that an untreated plant.
  • an amide compound having excellent plant disease controlling activity which is useful as an active ingredient of a plant disease controlling agent can be provided.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Plant Pathology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Agronomy & Crop Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Disclosed is an amide compound represented by the formula (1) below, which has excellent plant disease controlling activity.
Figure imga0001
 In the formula, X1 represents a fluorine atom or a methoxy group; X2 represents a chlorine atom, a bromine atom, an iodine atom, a C1-C4 alkyl group or the like; Z represents an oxygen atom or a sulfur atom; and A represents an A1-CR11R12R13 group or A2-Cy group, wherein A1 and A2 each represents a single bond or the like, R11 and R12 independently represent a C1-C4 alkyl group, R13 represents H, a C1-C4 alkyl group or the like, and Cy represents a C3-C6 cycloalkyl group or the like.

Description

    Technical Field
  • The present invention relates to an amide compound and use thereof.
    • Background Art
  • Drugs for controlling plant diseases have been conventionally developed. Compounds having plant disease controlling activity have been found out and have been put into practice.
    • Disclosure of Invention Problems to be solved by the invention
  • An object of the present invention is to provide a compound having excellent plant disease controlling activity.
    • Means for solving the problems
  • The present inventors studied in order to find out a compound having excellent plant disease controlling efficacy and, as a result, found that an amide compound represented by the following formula (1) has excellent plant disease controlling activity. Thus the present invention was completed.
    The present invention provides an amide compound represented by the formula (1):
    Figure imgb0001
     wherein,
    X1 represents a fluorine atom or a methoxy group,
    X2 represents a chlorine atom, a bromine atom, an iodine atom, a C1-C4 alkyl group, a C2-C4 alkenyl group, a C2-C4 alkynyl group, a C1-C4 haloalkyl group, a C2-C4 alkoxy group, a C1-C4 alkylthio group, a hydroxy C1-C4 alkly group, a nitro group, a cyano group, a formyl group, a NR1R2 group, a CO2R3 group, a CONR4R5 group, or a phenyl group optionally substituted with at least one group selected from the group consisting of a methyl group, a halogen atom, a cyano group and a nitro group,
    Z represents an oxygen atom or a sulfur atom,
    A represents an A1-CR11R12R13 group or A2-Cy group,
    A1 represents a single bond or a CH2 group,
    A2 represents a single bond, a CH2 group, a CH(CH3) group, a C(CH3)2 group or a CH(CH2CH3) group,
    Cy represents a C3-C6 cycloalkyl group optionally substituted with at least one group selected from the group consisting of a C1-C4 alkyl group, a C2-C4 alkenyl group, a C2-C6 alkynyl group, a halogen atom, a hydroxyl group, a cyano group, a carboxyl group and a C2-C5 alkoxycarbonyl group,
    R1 and R2 independently represent a hydrogen atom, a C1-C4 alkyl group, a C3-C4 alkenyl group, a C3-C4 alkynyl group, a C2-C4 haloalkyl group, a C2-C5 alkylcarbonyl group, a C2-C5 alkoxycarbonyl group or a C1-C4 alkylsulfonyl group,
    R3 represents a C1-C4 alkyl group, a C3-C4 alkenyl group or a C3-C4 alkynyl group,
    R4 represents a hydrogen atom, a C1-C4 alkyl group, a C3-C4 alkenyl group, a C3-C4 alkynyl group, a C2-C4 haloalkyl group, a C2-C5 alkylcarbonyl group, a C2-C5 alkoxycarbonyl group, or a C1-C4 alkylsulfonyl group,
    R5 represents a hydrogen atom, a C1-C4 alkyl group, a C3-C4 alkenyl group, a C3-C4 alkynyl group or a C2-C4 haloalkyl group,
    R11 and R12 independently represent a C1-C4 alkyl group, and
    R13 represents a hydrogen atom, a C1-C4 alkyl group, a C2-C4 alkenyl group, a C2-C4 alkynyl group, a cyano group, a carboxyl group or a C2-C5 alkoxycarbonyl group (hereinafter, referred to as the compound of the present invention), a plant disease controlling agent containing the compound of the present invention as an active ingredient, and a plant disease controlling method which comprises treating a plant or soil with an effective amount of the compound of the present invention.
    • Effect of the invention
  • The compound of the present invention has excellent plant disease controlling activity and therefore, it is useful as an active ingredient of a plant disease controlling agent.
    • Best Mode for Carrying Out the Invention
  • In the present invention, examples of the C1-C4 alkyl group represented by X2 include a methyl group, an ethyl group, a 1-methylethyl group, a 1,1-dimethylethyl group, a propyl group and a 1-methylpropyl group.
    Examples of the C2-C4 alkenyl group represented by X2 include a vinyl group, a 1-propenyl group, a 2-propenyl group, a 2-butenyl group and a 3-butenyl group.
    Examples of the C2-C4 alkynyl group represented by X2 include an ethynyl group, a 1-propynyl group, a 2-propynyl group, a 3-butynyl group.
    Examples of the C1-C4 haloalkyl group represented by X2 include a fluoromethyl group, a chloromethyl group, a bromomethyl group, a difluoromethyl group, a dichloromethyl group, a dibromomethyl group, a trifluoromethyl group, a trichloromethyl group, a dichlorofluoromethyl group, a chlorodifluoromethyl group, a 1,1-difluoroethyl group, a 2,2,2-trifluoroethyl group, a 2-fluoroethyl group, a 3-fluoropropyl group, a 4-fluorobutyl group and a 1-chloroethyl group.
    Examples of the C2-C4 alkoxy group represented by X2 include an ethoxy group, a 1-methylethoxy group, a 1,1-dimethylethoxy group, a propoxy group, a 1-methylpropoxy group, a 2-methylpropoxy group and a butoxy group.
    Examples of the C1-C4 alkylthio group represented by X2 include a methylthio group, an ethylthio group, a 1-methylethylthio group, a 1,1-dimethylethylthio group, a propylthio group and a 1-methylpropylthio group.
    Examples of the hydroxyl C1-C4 alkyl group represented by X2 include a hydroxymethyl group, a 1-hydroxyethyl group and a 2-hydroxyethyl group.
    Examples of the phenyl group optionally substituted with at least one group selected from the group consisting of a methyl group, a halogen atom, a cyano group and a nitro group which is represented by X2 include a phenyl group, a 2-methylphenyl group, a 3-methylphenyl group, a 4-methylphenyl group, a 2-fluorophenyl group, a 3-fluorophenyl group, a 4-fluorophenyl group, a 2-chlorophenyl group, a 3-chlorophenyl group, a 4-chlorophenyl group, a 4-cyanophenyl group and a 4-nitrophenyl group.
  • Examples of the C1-C4 alkyl group represented by R1 include a methyl group, an ethyl group, a 1-methylethyl group, a 1,1-dimethylethyl group, a propyl group and a 1-methylpropyl group. Examples of the C3-C4 alkenyl group represented by R1 include a 1-propenyl group, a 2-propenyl group, a 2-butenyl group and a 3-butenyl group.
    Examples of the C3-C4 alkynyl group represented by R1 include a 1-propynyl group, a 2-propynyl group and a 3-butynyl group.
    Examples of the C2-C4 haloalkyl group represented by R1 include a 1,1-difluoroethyl group, a 2,2,2-trifluoroethyl group, a 2-fluoroethyl group, a 3-fluoropropyl group, a 4-fluorobutyl group and a 1-chloroethyl group.
    Examples of the C2-C5 alkylcarbonyl group represented by R1 include an acetyl group, an ethylcarbonyl group, a 1-methylethyloarboryl group and a 1,1-dimethylethylcarbonyl group.
    Examples of the C2-C5 alkoxycarbonyl group represented by R1 include a methoxycarbonyl group, an ethoxycarbonyl group, a 1-methylethoxycarbonyl group and a 1,1-dimethylethoxycarbonyl group.
    Examples of the C1-C4 alkylsulfonyl group represented by R1 include a methylsulfonyl group, an ethylsulfonyl group, a 1-methylethylsulfonyl group and a 1,1-dimethylethylsulfonyl group.
    Examples of the C1-C4 alkyl group represented by R2 include a methyl group, an ethyl group, a 1-methylethyl group, a 1,1-dimethylethyl group, a propyl group and a 1-methylpropyl group.
    Examples of the C3-C4 alkenyl group represented by R2 include a 1-propenyl group, a 2-propenyl group, a 2-butenyl group and a 3-butenyl group.
    Examples of the C3-C4 alkynyl group represented by R2 include a 1-propynyl group, a 2-propynyl group and a 3-butynyl group.
    Examples of the C2-C4 haloalkyl group represented by R2 include a 1,1-difluoroethyl group, a 2,2,2-trifluoroethyl group, a 2-fluoroethyl group, a 3-fluoropropyl group, a 4-fluorobutyl group and a 1-chloroethyl group.
    Examples of the C2-C5 alkylcarbonyl group represented by R2 include an acetyl group, an ethylcarbonyl group, a 1-methylethylcarbonyl group and a 1,1-dimethylethylcarbonyl group.
    Examples of the C2-C5 alkoxycarbonyl group represented by R2 include a methoxycarbonyl group, an ethoxycarbonyl group, a 1-methylethoxycarbonyl group and a 1,1-dimethylethoxycarbonyl group.
    Examples of the C1-C4 alkylsulfonyl group represented by R2 include a methylsulfonyl group, an ethylsulfonyl group, a 1-methylethylsulfonyl group and a 1,1-dimethylethylsulfonyl group.
    Examples of the C1-C4 alkyl group represented by R3 include a methyl group, an ethyl group, a 1-methylethyl group, a 1,1-dimethylethyl group, a propyl group, and a 1-methylpropyl group. Examples of the C3-C4 alkenyl group represented by R3 include a 1-propenyl group, a 2-propenyl group, a 2-butenyl group and a 3-butenyl group.
    Examples of the C3-C4 alkynyl group represented by R3 include a 1-propynyl group, a 2-propynyl group, and a 3-butynyl group.
    Examples of the C1-C4 alkyl group represented by R4 include a methyl group, an ethyl group, a 1-methylethyl group, a 1,1-dimethylethyl group, a propyl group and a 1-methylpropyl group.
    Examples of the C3-C4 alkenyl group represented by R4 include a 1-propenyl group, a 2-propenyl group, a 2-butenyl group and a 3-butenyl group.
    Examples of the C3-C4 alkynyl group represented by R4 include a 1-propynyl group, a 2-propynyl group, and a 3-butynyl group.
    Examples of the C2-C4 haloalkyl group represented by R4 include a 1,1-difluoroethyl group, a 2,2,2-trifluroethyl group, a 2-fluoroethyl group, a 3-fluoropropyl group, a 4-fluorobutyl group, and a 1-chloroethyl group.
    Examples of the C2-C5 alkylcarbonyl group represented by P4 include an acetyl group, an ethylcarbonyl group, a 1-methylethylcarbonyl group and a 1,1-dimethylethylcarbonyl group.
    Examples of the C2-C5 alkoxycarbonyl group represented by R4 include a methoxycarbonyl group, an ethoxycarbornyl group, a 1-methylethoxycarbonyl group and a 1,1-dimethylethoxycarbonyl group.
    Examples of the C1-C4 alkylsulfonyl group represented by R4 include a methylsulfonyl group, an ethylsulfonyl group, a 1-methylethylsulfonyl group and a 1,1-dimethylethylsulfonyl group.
    Examples of the C1-C4 alkyl group represented by R5 include a methyl group, an ethyl group, a 1-methylethyl group, a 1,1-dimethylethyl group, a propyl group, and a 1-methylpropyl group.
    Examples of the C3-C4 alkenyl group represented by R5 include a 1-propenyl group, a 2-propenyl group, a 2-butenyl group and a 3-butenyl group.
    Examples of the C3-C4 alkynyl group represented by R5 include a 1-propynyl group, a 2-propynyl group and a 3-butynyl group.
    Examples of the C2-C4 haloalkyl group represented by R5 include a 1,1-difluoroethyl group, a 2,2,2-trifluoroethyl group, a 2-fluoroethyl group, a 3-fluoropropyl group, a 4-fluorobutyl group and a 1-chloroethyl group.
  • Examples of the NR1R2 group include an amino group, a methylamino group, a dimethylamino group, an ethylamino group, a 2-propenylamino group, a propynylamino group, a 2-chloroethylamino group, an acetylamino group, a propionylamino group, a 1,1-dimethylethylcarbonylamino group, a methoxycarbonylamino group, an ethoxycarbonylamino group, a methanesulfonylamino group, an N-acetyl-N-methylamino group, an N-ethoxycarbonyl-N-methylamino group and an N-methanesulfonyl-N-methylamino group.
    Examples of the CONR4R5 group include a carbamoyl group, a methylcarbamoyl group, a dimethylcarbamoyl group, an ethylmethylcarbamoyl group, a (2-propenyl)carbamoyl group, a (2-propynyl)carbamoyl group and a 2-chloroethylcarbamoyl group.
  • Examples of the C1-C4 alkyl group represented by R11 include a methyl group, an ethyl group, a 1-methylethyl group, a 1,1-dimethylethyl group, a propyl group, and a 1-methylpropyl group.
    Examples of the C1-C4 alkyl group represented by R12 include a methyl group, an ethyl group, a 1-methylethyl group, a 1,1-dimethylethyl group, a propyl group, and a 1-methylpropyl group.
    Examples of the C1-C4 alkyl group represented by R13 include a methyl group, an ethyl group, a 1-methylethyl group, a 1,1-dimethylethyl group, a propyl group, and a 1-methylpropyl group.
    Examples of the C2-C4 alkenyl group represented by R13 include a vinyl group, a 1-propenyl group, a 2-propenyl group, a 2-butenyl group and a 3-butenyl group.
    Examples of the C2-C4 alkynyl group represented by R13 include an ethynyl group, a 1-propynyl group, a 2-propynyl group and a 3-butynyl group.
    Examples of the C2-C5 alkoxycarbonyl group represented by R13 include a methoxycarbonyl group, an ethoxycarbonyl group and a 1-methylethoxycarbonyl group.
  • Examples of the group represented by CR11R12R13 include a 1-methylethyl group, a 1-methylpropyl group, a 1-methylbutyl group, a 1-methylpropyl group, a 1,1-diemethylethyl group, a 1,1-dimethylpropyl group, a 1,2-dimethylpropyl group, a 1,2-dimethylbutyl group, a 1,1,2-trimethylpropyl group, a 1,2,2-trimethylpropyl group, a 1,1,2,2-tetramethylpropyl group and a 1-cyano-1,2-dimethylpropyl group.
    In the C3-C6 cycloalkyl group optionally substituted with at least one group selected from the group consisting of a C1-C4 alkyl group, a C2-C4 alkenyl group, a C2-C4 alkynyl group, a halogen atom, a hydroxyl group, a cyano group, a carboxyl group and a C2-C5 alkoxycarbonyl group which is represented by Cy;
    examples of the C1-C4 alkyl group as a substituent include a methyl group, an ethyl group, a propyl group and an isopropyl group,
    examples of the C2-C4 alkenyl group as a substituent include a vinyl group, a 1-propenyl group, a 2-propenyl group, a 2-butenyl group and a 3-butenyl group,
    examples of the C2-C4 alkynyl group as a substituent include an ethynyl group, a 1-propynyl group, a 2-propynyl group and a 3-butynyl group,
    examples of the halogen atom as a substituent include a fluorine atom, a chlorine atom, a bromine atom, and an iodine atom, and
    examples of the C2-C5 alkoxycarbonyl group as a substituent include a methoxycarbonyl group and an ethoxycarbonyl group.
    Examples of the C3-C6 cycloalkyl in the C3-C6 cycloalkyl group optionally substitute with at least one group selected from the group consisting of a C1-C4 alkyl group, a C2-C4 alkenyl group, a C2-C4 alkynyl group, a chlorine atom, a hydroxyl group, a cyano group, a carboxyl group and a C2-C5 alkoxycarbonyl group which is represented by Cy include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, and a cyclohexyl group.
  • Examples of the group represented by A2-Cy specifically include the following groups:
    • a cyclopropyl group, a 2,2,3,3-tetramethylcyclopropyl group;
    • a cyclobutyl group;
    • a cyclopentyl group, a 2-methylcyclopentyl group, a 2-hydroxycyclopentyl group, a 2-chlorocyclopentyl group, a 2-bromocyclopentyl group, a 2,2-dimethylcyclopentyl group, a 2-fluoro-2-methylcyclopentyl group, a 2-chloro-2-methylcyclopentyl group, a 2-hydroxy-2-methylcyclopentyl group, a 2,2-difluorocyclopentyl group, a 3-methylcyclopentyl group;
    • a cyclohexyl group, a 1-methylcyclohexyl group, a 2-methylcyclohexyl group, a 3-methylcyclohexyl group, a 4-methylcyclohexyl group, a 2-trifluoromethylcyclohexyl group, a 2,2-dimethylcyclohexyl group, a 2-fluoro-2-methylcyclohexyl group, a 2-chloro-2-Tnethylcyclohexyl group, a 2-hydroxy-2-methylcyclohexyl group, a 2,2-difluorocyclohexyl group, a 2,3-dimethylcyclohexyl group, a 2,6-dimethylcyclohexyl group, a 2-ethylcyclohexyl group, a 2-chlorocyclohexyl group, a 2-fluorocyclohexyl group, a 2-bromocyclohexyl group, a 2-iodocyclohexyl group, a 2-hydroxycyclohexyl group, a 1-cyanocyclohexyl group, a 2-cyanocyclohexyl group, a 1-carboxycyclohexyl group a 1-(methoxycarbonyl)cyclohexyl group, a 1-(ethoxycarbonyl)cyclohexyl group, a 2-(methoxycarbonyl)cyclohexyl group, a 2-(ethoxycarbonyl)cyclohexyl group;
  • a cyclopropylmethyl group, a (1-methylcyclopropyl)methyl group, a (2-methylcyclopropyl)methyl group, a (1-hydroxycyclopropyl)methyl group, a (2-hydroxycyclopropyl)methyl group, a 2,2,3,3-tetramethylcyclopropyl)methyl group, a (1-fluorocyclopropyl)methyl group, a (1-chlorocyclopropyl)methyl group, a (1-cyanocyclopropyl)methyl group, a (1-ethoxycarbonylcyclopropyl)methyl group, a (1-methoxycarbonylcyclopropyl)methyl group;
    a cyclobutylmethyl group, a (1-methylcyclobutyl)methyl group, a (2-methylcyclobutyl)methyl group, a (3-methylcyclobutyl)methyl group, a (1-hydroxycyclobutyl)methyl group, a (2-hydroxycyclobutyl)methyl group, a (3-hydroxycyclobutyl)methyl group, a (1-fluorocyclobutyl)methyl group, a (1-chloracyclobutyl)methyl group, a (1-cyanocyclobutyl)methyl group, a (1-ethoxycarbonylcyclobutyl)methyl group, a (1-methoxycarbonylcyclobutyl)methyl group;
    a cyclopentylmethyl group, a (1-methylcyclopentylmehyl) group, a (2-methylcyclopentyl)methyl group, a (3-methylcyclopentyl)methyl group, a (1-hydroxycyclopentyl)methyl group, a (2-hydroxycyclopentyl)methyl group, a (3-hydroxycyclopentyl)methyl group, a (1-fluorocyclopentyl)methyl group, a (1-chlorocyclopentyl)methyl group, a (1-cyanocyclopentyl)methyl group, a (1-ethoxycarbonylcyclopentyl)methyl group, a (1-methoxycarbonylcyclopenyl)methyl group;
    a cyclohexylmethyl group, a (1-methylcyclohexyl)methyl group, a (2-methylcyclohexyl)methyl group, a (3-methylcyclohexyl)methyl group, a (4-methylcyclohexyl)methyl group, a (2,3-dimethylcyclohexyl)methyl group, a (1-hydroxycyclohexyl)methyl group, a (2-hydroxycyclohexyl)methyl group, a (3-hydroxycyclohexyl)methyl group, a (4-hydroxycyclohexyl)methyl group, a (1-fluorocyclohexyl)methyl group, a (1-chlorocyclohexyl)methyl group, a (1-cyanocyclohexyl)methyl group, a (1-ethoxycarbonylcyclohexyl)methyl group, a (1-methoxycarbonylcyclohexyl)methyl group, a (1-ethynylcyclohexyl)methyl group, a (2-fluorocyclohexyl)methyl group, a (2-chlorocyclohexyl)methyl group, a (2-cyanocyclohexyl)methyl group, a (2-ethoxycarbonylcyclohexyl)methyl group, a (2-methoxycarbonylcyclohexyl)methyl group;
  • a 1-(cyclopropyl)ethyl group, a 1-(1-methylcyclopropyl)ethyl group, a 1-(2-methylcyclopropyl)ethyl group, a 1-(1-hydroxycyclopropyl)ethyl group, a 1-(2-hydroxycyclopropyl)ethyl group, a 1-(2,2,3,3-tetramethylcyclopropyl)ethyl group, a 1-(1-fluorocyclopropyl)ethyl group, a 1-(1-chlorocyclopropyl)ethyl group, a 1-(1-cyanocyclopropyl)ethyl group, a 1-(1-ethoxycarbonylcylclopropyl)ethyl group, a 1-(1-methoxycarbonylcyclopropyl)ethyl group;
    a 1-(cyclobutyl)ethyl group, a 1-(1-methylcyolobutyl)ethyl group, a 1-(2-methylcyclobutyl)ethyl group, a 1-(3-methylcyolobutyl)ethyl group,
    a 1-(1-hydroxycyclobutyl)ethyl group, a 1-(2-hydroxycyclobutyl)ethyl group, a 1-(3-hydroxycyclobutyl)ethyl group, a 1-(1-fluorocyclobutyl)ethyl group, a 1-(l-chlorocyclobutyl)ethyl group, a 1-(1-cyanocyclobutyl)ethyl group, a 1-(1-ethoxycarbonylcyclobutyl)ethyl group, a 1-(1-methoxycarbonylcyclobutyl)ethyl group;
    a 1-(cyclopentyl)ethyl group, a 1-(1-methylcyclopentyl)ethyl group, a 1-(2-methylcyclopentyl)ethyl group, a 1-(3-methylcyclopentyl)ethyl group, a 1-(1-hydroxycyclopentyl)ethyl group, a 1-(2-hydroxycyclopentyl)ethyl group, a 1-(3-hydroxycyclopentyl)ethyl group, a 1-(1-fluorocyclopentyl)ethyl group, a 1-(1-chlorocyclopentyl)ethyl group, a 1-(1-cyanocyclopentyl)ethyl group, a 1-(1-ethoxycarbonylcyclopentyl)ethyl group, a 1-(1-methoxycarbonylcyclopentyl)ethyl group;
    a 1-(cyclohexyl)ethyl group, a 1-(1-methylcyclohexyl)ethyl group, a 1-(2-methylcyclohexyl)ethyl group, a 1-(3-methylcyclohexyl)ethyl group, a 1-(4-methylcyclohexyl)ethyl group, a 1-(2,3-dimethylcyclohexyl)ethyl group, a 1-(1-hydroxycyclohexyl)ethyl group, a 1-(2-hydroxycyclohexyl)ethyl group, a 1-(3-hydroxycyclohexyl)ethyl group, a 1-(4-hydroxycyclohexyl)ethyl group, a 1-(1-fluorocyclohexyl)ethyl group, a 1-(1-chlorocyclohexyl)ethyl group, a 1-(1-cyanocyclohexyl)ethyl group, a 1-(1-ethoxycarbonylcyclohexyl)ethyl group, a 1-(1-methoxycarbonylcyclohexyl)ethyl group, a 1-(1-ethynylcyclohexyl)ethyl group, a 1-(2-fluorocyclohexyl)ethyl group, a 1-(2-chlorocyclohexyl)ethyl group, a 1-(2-cyanocyclohexyl)ethyl group, a 1-(2-ethoxycarbonylcyclohexyl)ethyl group, a 1-(2-methoxycarbonylcyclohexyl)ethyl group;
    a 1-methyl-1-cyclopropylethyl group, a 1-methyl-1-cyclobutylethyl group, a 1-methyl-1-(1-hydroxycyclobutyl)ethyl group, a 1-methyl-1-(1-fluorocyclobutyl)ethyl group, a 1-methyl-l-cyclopentylethyl group, a 1-methyl-1-(1-hydrdoxycylcopentyl)ethyl group, a 1-methyl-1-(1-tluorocyclopentyl)ethyl group, a 1-methyl-1-cyclohexylethyl group, a 1-methyl-1-(1-hydroxycyclohexyl)ethyl group and a 1-methyl-1-(1-fluorocyclohexyl)ethyl group.
  • Examples of the compound of the present invention include the following embodiments:
    • an amide compound of the formula (1), wherein Z is an oxygen atom, X1 is a fluorine atom, and X2 is a chlorine atom;
    • an amide compound of the formula (1), wherein Z is an oxygen atom, X1 is a fluorine atom, and X2 is a bromine atom;
    • an amide compound of the formula (1), wherein Z is an oxygen atom, X1 is a fluorine atom, and X2 is an iodine atom;
    • an amide compound of the formula (1), wherein Z is an oxygen atom, X1 is a fluorine atom, and X2 is a C1-C4 alkyl group;
    • an amide compound of the formula (1), wherein Z is an oxygen atom, X1 is a fluorine atom, and X2 is a C2-C4 alkenyl group;
    • an amide compound of the formula (1), wherein Z is an oxygen atom, X1 is a fluorine atom, and X2 is a C2-C4 alkynyl group;
    • an amide compound of the formula (1), wherein Z is an oxygen atom, X1 is a fluorine atom, and X2 is a C1-C4 haloalkyl group;
    • an amide compound of the formula (1), wherein Z is an oxygen atom, X1 is a fluorine atom, and X2 is a C2-C4 alkoxy group;
    • an amide compound of the formula (1), wherein Z is an oxygen atom, X1 is a fluorine atom, and X2 is a C1-C4 alkylthio group;
    • an amide compound of the formula (1), wherein Z is an oxygen atom, X1 is a fluorine atom, and X2 is a hydroxy C1-C4 alkyl group;
    • an amide compound of the formula (1), wherein Z is an oxygen atom, X1 is a fluorine atom, and X2 is a nitro group;
    • an amide compound of the formula (1), wherein Z is an oxygen atom, X1 is a fluorine atom, and X2 is a cyano group;
    • an amide compound of the formula (1), wherein Z is an oxygen atom, X1 is a fluorine atom, and X2 is a formyl group;
    • an amide compound of the formula (1), wherein Z is an oxygen atom, X1 is a fluorine atom, and X2 is an NR1R2 group;
    • an amide compound of the formula (1), wherein Z is an oxygen atom, X1 is a fluorine atom, and X2 is a CO2R3 group;
    • an amide compound of the formula (1), wherein Z is an oxygen atom, X1 is a fluorine atom, and X2 is a CONR4R5 group;
    • an amide compound of the formula (1), wherein Z is an oxygen atom, X1 is a fluorine atom, and X2 is a phenyl group optionally substituted with at least one group selected from the group consisting of a methyl group, a halogen atom, a cyano group and a nitro group;
  • an amide compound of the formula (1), wherein Z is an oxygen atom, X1 is a methoxy group, and X2 is a chlorine atom;
    an amide compound of the formula (1), wherein Z is an oxygen atom, X1 is a methoxy group, and X2 is a bromine atom;
    an amide compound of the formula (1), wherein Z is an oxygen atom, X1 is a methoxy group, and X2 is an iodine atom;
    an amide compound of the formula (1), wherein Z is an oxygen atom, X1 is a methoxy group, and X2 is a C1-C4 alkyl group;
    an amide compound of the formula (1), wherein Z is an oxygen atom, X1 is a methoxy group, and X2 is a C2-C4 alkenyl group;
    an amide compound of the formula (1), wherein Z is an oxygen atom, X1 is a methoxy group, and X2 is a C2-C4 alkynyl group;
    an amide compound of the formula (1), wherein Z is an oxygen atom, X1 is a methoxy group, and X2 is a C1-C4 haloalkyl group;
    an amide compound of the formula (1), wherein Z is an oxygen atom, X1 is a methoxy group, and X2 is a C2-C4 alkoxy group;
    an amide compound of the formula (1), wherein Z is an oxygen atom, X1 is a methoxy group, and X2 is a C1-C4 alkylthio group;
    an amide compound of the formula (1), wherein Z is an oxygen atom, X1 is a methoxy group, and X2 is a hydroxy C1-C4 alkyl group;
    an amide compound of the formula (1), wherein Z is an oxygen atom, X1 is a methoxy group, and X2 is a nitro group;
    an amide compound of the formula (1), wherein Z is an oxygen atom, X1 is a methoxy group, and X2 is a cyano group;
    an amide compound of the formula (1), wherein Z is an oxygen atom, X1 is a methoxy group, and X2 is a formyl group;
    an amide compound of the formula (1), wherein Z is an oxygen atom, X1 is a methoxy group, and X2 is an NR1R2 group;
    an amide compound of the formula (1), wherein Z is an oxygen atom, X1 is a methoxy group, and X2 is a CO2R3 group;
    an amide compound of the formula (1), wherein Z is an oxygen atom, X1 is a methoxy group, and X2 is a CONR4R5 group;
    an amide compound of the formula (1), wherein Z is an oxygen atom, X1 is a methoxy group, and X2 is a phenyl group optionally substituted with at least one group selected from the group consisting of a methyl group, a halogen atom, a cyano group and a nitro group;
  • an amide compound of the formula (1), wherein Z is an oxygen atom;
    an amide compound of the formula (1), wherein X1 is a fluorine atom;
    an amide compound of the formula (1), wherein X1 is a methoxy group;
    an amide compound of the formula (1), wherein Z is an oxygen atom, and X1 is a fluorine atom;
    an amide compound of the formula (1), wherein Z is an oxygen atom, and X1 is a methoxy group;
    an amide compound of the formula (1), wherein X2 is a chlorine atom, a bromine atom or a C1-C4 alkyl group;
    an amide compound of the formula (1), wherein X2 is a chlorine atom or a C1-C4 alkyl group;
    an amide compound of the formula (1), wherein X2 is a chlorine atom;
    an amide compound of the formula (1), wherein X2 is a C1-C4 alkyl group;
    an amide compound of the formula (1), wherein Z is an oxygen atom, and X2 is a chlorine atom or a C1-C4 alkyl group;
    an amide compound of the formula (1), wherein Z is an oxygen atom, and X2 is a chlorine atom;
    an amide compound of the formula (1), wherein Z is an oxygen atom, and X2 is a C1-C4 alkyl group;
  • an amide compound of the formula (1), wherein A is A1-CR11R12R13;
    an amide compound of the formula (1), wherein A is A1-CR11R12R13, R11 is a methyl group or an ethyl group, and R12 is a methyl group, an ethyl group, a 1-methylethyl group, a 1,1-dimethylethyl group or a 1-methylpropyl group;
    an amide compound of the formula (1), wherein A is A1-CR11R12R13, and R13 is a hydrogen atom or a methyl group;
    an amide compound of the formula (1), wherein A is A1-CR11R12R13, A1 is a single bond, R11 is a methyl group, R12 is a 1-methylethyl group or a 1,1-dimethylethyl group, and R13 is a hydrogen atom;
    an amide compound of the formula (1), wherein A is A2-Cy;
    an amide compound of the formula (1), wherein A is A2-Cy, and A2 is a single bond;
    an amide compound of the formula (1), wherein A is A2-Cy, and A2 is a CH2 group;
    an amide compound of the formula (1), wherein A is A2-Cy, and A2 is a CH (CH3) group;
  • an amide compound of the formula (1), wherein A is A2-Cy, and Cy is a C3-C6 cycloalkyl group optionally substituted with at least one group selected from the group consisting of a C1-C4 alkyl group, a halogen atom, a hydroxyl group and a cyano group;
    an amide compound of the formula (1), wherein A is A2-Cy, and Cy is a cyclopropyl group optionally substituted with at least one group selected from the group consisting of a C1-C4 alkyl group, a halogen atom, a hydroxyl group and a cyano group;
    an amide compound of the formula (1), wherein A is A2-Cy, and Cy is a cyclobutyl group optionally substituted with at least one group selected from the group consisting of a C1-C4 alkyl group, a halogen atom, a hydroxyl group and a cyano group;
    an amide compound of the formula (1), wherein A is A2-Cy, and Cy is a cyclopentyl group optionally substituted with at least one group selected from the group consisting of a C1-C4 alkyl group, a halogen atom, a hydroxyl group and a cyano group;
    an amide compound of the formula (1), wherein A is A2-Cy, and Cy is a cyclohexyl group optionally substituted with at least one group selected from the group consisting of a C1-C4 alkyl group, a halogen atom, a hydroxyl group and a cyano group;
  • an amide compound of the formula (1), wherein A is A2-Cy, A2 is a single bond, and Cy is a cyclohexyl group optionally substituted with at least one group selected from the group consisting of a methyl group, a halogen atom and a hydroxyl group;
    an amide compound of the formula (1), wherein A is A2-Cy, A2 is a CH2 group, and Cy is a cyclohexyl group optionally substituted with at least one group selected from the group consisting of a methyl group, a halogen atom and a hydroxyl group;
    an amide compound of the formula (1), wherein A is A2-Cy, A2 is a CH(CH3) group, and Cy is a cyclohexyl group optionally substituted with at least one group selected from the group consisting of a methyl group, a halogen atom and a hydroxyl group;
    an amide compound of the formula (1), wherein A is A2-Cy, A2 is a single bond, and Cy is a cyclopentyl group optionally substituted with at least one group selected from the group consisting of a methyl group, a halogen atom and a hydroxyl group;
    an amide compound of the formula (1), wherein A is A2-Cy, A2 is a CH2 group, and Cy is a cyclopentyl group optionally substituted with at least one group selected from the group consisting of a methyl group, a halogen atom and a hydroxyl group;
    an amide compound of the formula (1), wherein A is A2-Cy, A2 is a CH(CH3) group, and Cy is a cyclopentyl group optionally substituted with at least one group selected from the group consisting of a methyl group, a halogen atom and a hydroxyl group;
    an amide compound of the formula (1), wherein A is A2-Cy, A2 is a single bond, and Cy is a cyclobutyl group optionally substituted with at least one group selected from the group consisting of a methyl group, a halogen atom and a hydroxyl group;
    an amide compound of the formula (1), wherein A is A2-Cy, A2 is a CH2 group, and Cy is a cyclobutyl group optionally substituted with at least one group selected from the group consisting of a methyl group, a halogen atom and a hydroxyl group;
    an amide compound of the formula (1), wherein A is A2-Cy, A2 is a CH(CH3) group, and Cy is a cyclobutyl group optionally substituted with at least one group selected from the group consisting of a methyl group, a halogen atom and a hydroxyl group;
  • an amide compound of the formula (1), wherein A is A2-Cy, and Cy is a C4-C6 cycloalkyl group optionally substituted with a methyl group;
    an amide compound of the formula (1), wherein A is A2-Cy, and Cy is a C4-C6 cycloalkyl group optionally substituted with a halogen atom;
    an amide compound of the formula (1), wherein A is A2-Cy, and Cy is a C4-C6 cycloalkyl group optionally substituted with a fluorine atom;
    an amide compound of the formula (1), wherein A is A2-Cy, and Cy is a C4-C6 cycloalkyl group optionally substituted with a chlorine atom;
    an amide compound of the formula (1), wherein A is A2-Cy, and Cy is a C4-C6 cycloalkyl group optionally substituted with a hydroxyl group;
    an amide compound of the formula (1), wherein A is A2-Cy, and Cy is a C4-C6 cycloalkyl group optionally substituted with a halogen atom;
    an amide compound of the formula (1), wherein A is a 2-methylcyclopentyl group, a 2-fluorocyclopentyl group, a 2-chlorocyclopentyl group, a 2-hydroxycyclopentyl group, a 2-methylcyclohexyl group, a 2-fluorocyclohexyl group, a 2-chlorocyclohexyl group, a 2-hydroxycyclohexyl group, a cyclobutylmethyl group, a cyclopentylmethyl group, a cyclohexylmethyl group, a (1-hydroxycyclobutyl)methyl group, a (1-hydroxycyclopentyl)methyl group, a (1-hydroxycyclohexyl)methyl group, a 1-cyclobutylethyl group, a 1-cyclopentylethyl group, a 1-cyclohexylethyl group, a 1-(1-hydroxycyclobutyl)ethyl group, a 1-(1-hydroxycyclopentyl)ethyl group or a 1-(1-hydroxycyclohexyl)ethyl group;
    an amide compound of the formula (1), wherein A is a 2-methylcyclopentyl group, a 2-fluorocyclopentyl group, a 2-chlorocyclopentyl group, a 2-hydroxycyclopentyl group, a 2-methylcyclohexyl group, a 2-fluorocyclohexyl group, a 2-chlorocyclohexyl group or a 2-hydroxycyclohexyl group;
    an amide compound of the formula (1), wherein A is a cyclobutylmethyl group, a cyclopentylmethyl group, a cyclohexylmethyl group, a (1-hydroxycyclobutyl)methyl group, a (1-hydroxycyclopentyl)methyl group, a (1-hydroxycyclohexyl)methyl group, a 1-cyclobutylethyl group, a 1-cyclopentylethyl group, a 1-cyclohexylethyl group, a 1-(1-hydroxycyclobutyl)ethyl group, a 1-(1-hydroxycyclopentyl)ethyl group or a 1-(1-hydroxycyclohexyl)ethyl group;
  • an amide compound of the formula (1), wherein X2 is a chlorine atom or a C1-C4 alkyl group, and A is A2-Cy;
    an amide compound of the formula (1), wherein X2 is a chlorine atom or a C1-C4 alkyl group, A is A2-Cy, and A2 is a single bond or a CH2 group;
    an amide compound of the formula (1), wherein X2 is a chlorine atom or a C1-C4 alkyl group, A is A2-Cy, A2 is a single bond or a CH2 group, and Cy is a C3-C6 cycloalkyl group optionally substituted with at least one group selected from the group consisting of a C1-C4 alkyl group and a hydroxyl group;
    an amide compound of the formula (1), wherein X2 is a chlorine atom or a C1-C4 alkyl group, A is A2-Cy, A2 is a single bond or a CH2 group, and Cy is a C5-C6 cycloalkyl group optionally substituted with at least one group selected from the group consisting of a C1-C4 alkyl group and a hydroxyl group;
    an amide compound of the formula (1), wherein Z is an oxygen atom, X2 is a chlorine atom or a C1-C4 alkyl group, A is A2-Cy, and A2 is a single bond or a CH2 group;
    an amide compound of the formula (1), wherein Z is an oxygen atom, X2 is a chlorine atom or a C1-C4 alkyl group, A is A2-Cy, A2 is a single bond or a CH2 group, and Cy is a C3-C6 cycloalkyl group optionally substituted with at least one group selected from the group consisting of a C1-C4 alkyl group and a hydroxyl group;
    an amide compound of the formula (1), Z is an oxygen atom, X2 is a chlorine atom or a C1-C4 alkyl group, A is A2-Cy, A2 is a single bond or a CH2 group, and Cy is a C5-C6 cycloalkyl group optionally substituted with at least one group selected from the group consisting of a C1-C4 alkyl group and a hydroxyl group;
  • an amide compound of the formula (1), wherein A is a 2-methylcyclohexyl group;
    an amide compound of the formula (1), wherein A is a 2-chlorocyclohexyl group;
    an amide compound of the formula (1), wherein A is a cyclohexylmethyl group;
    an amide compound of the formula (1), wherein A is a (1-hydroxycyclohexyl)methyl group;
    an amide compound of the formula (1), wherein A is a 1-(1-hydroxycyclohexyl)ethyl group;
    an amide compound of the formula (1), wherein A is a cyclobutylmethyl group;
    an amide compound of the formula (1), wherein A is a (1-hydroxycyclobutyl)methyl group;
    an amide compound of the formula (1), wherein A is a 1-(1-hydroxycyclobutyl)ethyl group;
    an amide compound of the formula (1), wherein Z is an oxygen atom, and A is a 2-methylcyclohexyl group;
    an amide compound of the formula (1), wherein Z is an oxygen atom, and A is a 2-chlorocyclohexyl group;
    an amide compound of the formula (1), wherein Z is an oxygen atom, and A is a cyclohexylmethyl group;
    an amide compound of the formula (1), wherein Z is an oxygen atom, and A is a (1-hydroxycyclohexyl)methyl group;
    an amide compound of the formula (1), wherein Z is an oxygen atom, and A is a 1-(1-hydroxycyclohexyl)ethyl group;
    an amide compound of the formula (1), wherein Z is an oxygen atom, and A is a cyclobutylmethyl group;
    an amide compound of the formula (1), wherein Z is an oxygen atom, and A is a (1-hydroxycyclobutyl)methyl group; and
    an amide compound of the formula (1), wherein Z is an oxygen atom, and A is a 1-(1-hydroxycyclobutyl)ethyl group.
  • In the specification, a structural formula of a compound may conveniently represent a specific isomer. However, the present invention includes all active isomers such as geometrical isomers, optical isomers, steric isomers and tautomers which may be generated due to the structure of a compound, and a mixture of isomers. In the present invention, a compound is not limited to the description of a specific formula conveniently described and may be any one of isomers or a mixture of isomers. Therefore, in the present invention, a compound may have an asymmetric carbon atom in its molecule and thus may exist as an optically active form or a racemate. In the present invention, there is no limitation, and all cases are included.
  • Then, a process for producing the compound of the present invention is explained.
    The compound of the present invention can be produced, for example, by the following Production process 1 to Production process 7.
    • (Production process 1)
  • Of compounds of the present invention, a compound (5) of the present invention in which Z is an oxygen atom can be produced by reacting a compound (2) and a compound (3) in the presence of a dehydration condensing agent.
    Figure imgb0002
     In the formulae, A, X1 and X2 are as defined above.
    The reaction is usually performed in the presence of a solvent.
    Examples of the solvent used in the reaction include ethers such as tetrahydrofuran (hereinafter, referred to as THF in some cases), ethylene glycol dimethyl ether and tert-butyl methyl ether (hereinafter, referred to as MTBE in some cases), aliphatic hydrocarbons such as hexane, heptane and octane, aromatic hydrocarbons such as toluene and xylene, halogenated hydrocarbons such as chlorobenzene, esters such as butyl acetate and ethyl acetate, nitriles such as acetonitrile, acid amides such as N,N-dimethylformamide (hereinafter, referred to as DMF in some cases), sulfoxides such as dimethyl sulfoxide (hereinafter, referred to as DMSO in some cases), and a mixture thereof.
    Examples of the dehydration condensing agent used in the reaction include carbodiimides such as 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (hereinafter, referred to as WSC) and 1,3-dicyclohexylcarbodiimide.
    The used amount of the compound (3) is usually 1 to 3 mol per 1 mol of the compound (2). The used amount of the dehydration condensing agent is usually 1 to 5 mol per 1 mol of the compound (2).
    The reaction temperature is usually in a range of from 0 to 140°C, and the reaction time is usually in a range of from 1 to 24 hours.
    After completion of the reaction, the compound (5) of the present invention can be isolated by post-treatment such as filtration of the reaction mixture, extraction of the filtrate with an organic solvent, and drying and concentration of an organic layer.
    The isolated compound (5) of the present invention can be further purified by chromatography, recrystallization or the like.
    • (Production process 2)
  • Of compounds of the present invention, a compound (5) of the present invention in which Z is an oxygen atom can be produced by reacting a compound (2) and a compound (4) in the presence of a base.
    Figure imgb0003
     In the formulae, A, X1 and X2 are as defined above.
    The reaction is usually performed in the presence of a solvent.
    Examples of the solvent used in the reaction include ethers such as THF, ethylene glycol dimethyl ether and MTBE, aliphatic hydrocarbons such as hexane, heptane and octane, aromatic hydrocarbons such as toluene and xylene, halogenated hydrocarbons such as chlorobenzene, esters such as butyl acetate and ethyl acetate, nitriles such as acetonitriles, acid amides such as DMF, sulfoxides such as DMSO, and a mixture thereof.
    Examples of the base used in the reaction include alkali metal carbonates such as sodium carbonate and potassium carbonate, tertiary amines such as triethyl amine and diisopropylethylamine, and nitrogen-containing aromatic compounds such as pyridine and 4-dimethylaminopyridine.
    The used amount of the compound (4) is usually 1 to 3 mol per 1 mol of the compound (2). The used amount of the base is usually 1 to 10 mol per 1 mol of the compound (2).
    The reaction temperature is usually in a range of from -20 to 100°C, and the reaction time is usually in a range of from 0.1 to 24 hours.
    After completion of the reaction, the compound (5) of the present invention can be isolated by post-treatment such as filtration of the reaction mixture, extraction of the filtrate with an organic solvent, and drying and concentration of an organic layer.
    The isolated compound (5) of the present invention can be further purified by chromatography, recrystallization or the like.
    • (Production process 3)
  • Of compounds of the present invention, a compound (6) of the present invention in which Z is a sulfur atom can be produced by reacting the compound (5) of the present invention in which Z is an oxygen atom and 2,4-bis(4-methoxyphenyl)-1,3-dithia-2,4-diphosphethane-2,4-disulfide (hereinafter, referred to as Lawesson's reagent).
    Figure imgb0004
     In the formulae, A, X1 and X2 are as defined above.
    The reaction is usually performed in the presence of a solvent.
    Examples of the solvent used in the reaction include ethers such as THF, ethylene glycol dimethyl ether and MTBE, aliphatic hydrocarbons such as hexane, heptane and octane, aromatic hydrocarbons such as toluene and xylene, halogenated hydrocarbons such as chlorobenzene, organic nitriles such as acetonitrile and butyronitrile, sulfoxides such as dimethyl sulfoxide, and a mixture thereof.
    The used amount of the Lawesson's reagent is usually 1 to 2 mol per 1 mol of the compound (5) of the present invention.
    The reaction temperature is usually in a range of from 25 to 150°C, and the reaction time is a usually in a range of from 0.1 to 24 hours.
    After completion of the reaction, the compound (6) of the present invention can be isolated by post-treatment such as extraction of the reaction mixture with an organic solvent, and drying and concentration of an organic layer. The isolated compound (6) of the present invention can be further purified by chromatography, recrystallization or the like.
    • (Production process 4)
  • Of compounds of the present invention, a compound (9) of the present invention in which Z is an oxygen atom and X1 is a fluorine atom can be produced by reacting a compound (7) and a compound (2) in the presence of a base to obtain a compound (8) (step (IV-1)) and then reacting the compound (8) and propargyl alcohol in the presence of a base (step (IV-2)).
    Figure imgb0005
     In the formulae, A and X2 are as defined above.
    • Step (IV-1)
  • The reaction is usually performed in the presence of a solvent.
    Examples of the solvent used in the reaction include ethers such as THF, ethylene glycol dimethyl ether and MTBE, aliphatic hydrocarbons such as hexane, heptane and octane, aromatic hydrocarbons such as toluene and xylene, halogenated hydrocarbons such as chlorobenzene, esters such as butyl acetate and ethyl acetate, nitriles such as acetonitrile, acid amides such as DMF, sulfoxides such as dimethyl sulfoxide, and a mixture thereof.
    Examples of the base used in the reaction include alkali metal carbonates such as sodium carbonate and potassium carbonate, tertiary amines such as triethylamine and diisopropylethylamine, and nitrogen-containing aromatic compounds such as pyridine and 4-dimethylaminopyridine.
    The used amount of the compound (7) is usually 1 to 3 mol per 1 mol of the compound (2). The used amount of the base usually 1 to 10 mol per 1 mol of the compound (2).
    The reaction temperature is usually in a range of from -20 to 100°C, and the reaction time is usually in a range of from 0.1 to 24 hours.
    After completion of the reaction, the compound (8) can be isolated by post-treatment such as extraction of the reaction mixture with an organic solvent, and drying and concentration of an organic layer. The isolated compound (8) can be further purified by chromatography, recrystallization or the like.
    • Step (IV-2)
  • The reaction is usually performed in the presence of a solvent.
    Examples of the solvent used in the reaction include ethers such as THF, ethylene glycol dimethyl ether and MTBE, aliphatic hydrocarbons such as hexane, heptane and octane, ketones such as acetone, methyl ethyl ketone and methyl isobutyl ketone, aromatic hydrocarbons such as toluene and xylene, halogenated hydrocarbons such as chlorobenzene, esters such as butyl acetate and ethyl acetate, nitriles such as acetonitrile, acid amides such as DMF, sulfoxides such as dimethyl sulfoxide, and a mixture thereof.
    Examples of the base used in the reaction include alkali metal carbonates such as sodium carbonate and potassium carbonate, alkali metal hydrogen carbonates such as sodium hydrogen carbonate, alkali metal hydrides such as sodium hydride, and alkali metal hydroxides such as sodium hydroxide.
    The used amount of propargyl alcohol is usually 1 to 3 mol per 1 mol of the compound (8). The used amount of the base is usually 1 to 2 mol per 1 mol of the compound (8).
    The reaction temperature is usually in a range of from -20 to 100°C, and the reaction time is usually in a range of from 0.1 to 24 hours.
    After completion of the reaction, the compound (9) of the present invention can be isolated by post-treatment such as extraction of the reaction mixture with an organic solvent, and drying and concentration of an organic layer. The isolated compound (9) of the present invention can be further purified by chromatography, recrystallization or the like.
    • (Production process 5)
  • Of compounds of the present invention, a compound (5) of the present invention in which Z is an oxygen atom can be produced by reacting a compound (10) and propargyl bromide in the presence of a base.
    Figure imgb0006
     In the formulae, A, X1 and X2 are as defined above.
    The reaction is usually performed in the presence of a solvent.
    Examples of the solvent used in the reaction include ethers such as THF, ethylene glycol dimethyl ether and MTBE, aromatic hydrocarbons such as toluene and xylene, halogenated hydrocarbons such as chlorobenzene, nitriles such as acetonitrile, acid amides such as DMF, sulfoxides such as dimethyl sulfoxide, ketones such as acetone, methyl ethyl ketone and methyl isobutyl ketone, water, and a mixture thereof.
    Examples of the base used in the reaction include alkali metal carbonates such as sodium carbonate, potassium carbonate and cesium carbonate, alkali metal hydroxides such as sodium hydroxide, and alkali metal hydrides such as sodium hydride.
    The used amount of propargyl bromide is usually 1 to 3 mol per 1 mol of the compound (10). The used amount of the base is usually 1 to 3 mol per 1 mol of the compound (10).
    The reaction temperature is usually in a range of from -20 to 100°C, and the reaction time is usually in a range of from 0.1 to 24 hours.
    After completion of the reaction, the compound (5) of the present invention can be isolated by post-treatment such as extraction of the reaction mixture with an organic solvent, and drying and concentration of an organic layer. The isolated compound (5) of the present invention can be further purified by chromatography, recrystallization or the like.
    • (Production process 6)
  • Of compounds of the present invention, a compound (12) of the present invention in which Z is an oxygen atom, A is A2-Cy, A2 is a single bond, and Cy is a 2-fluorocyclohexyl group, a 2-chlorocyclohexyl group, a 2-bromocyclohexyl group, a 2-iodocyclohexyl group or a 2-cyanocyclohexyl group can be produced by a process shown in the following scheme. In addition, a compound (12) of the present invention in which R14 is a chlorine atom can be produced by reacting a compound (4) and 7-azabicyclo[4.1.0]heptane without isolation of an intermediate (11).
    Figure imgb0007
     In the formulae, X1 and X2 are as defined above, and R14 represents a fluorine atom, a chlorine atom, a bromine atom, an iodine atom or a cyano group.
    • Step (VI-1)
  • The compound (11) can be produced by reacting the compound (4) and 7-azabicyclo[4.1.0]heptane in the presence of a base according to the process described in Production process 2.
    • Step (VI-2)
  • The compound (12) of the present invention can be produced by reacting the compound (11) and the following reagent.
    Examples of the reagent used in the reaction, in the case where R14 in the compound (12) is a fluorine atom, include alkali metal fluorides such as potassium fluoride and lithium fluoride, alkaline earth metal fluorides such as calcium fluoride, quaternary ammonium fluorides such as tetrabutylammonium fluoride, and hydrogen fluoride.
    Examples of the reagent used in the reaction, in the case where R14 in the compound (12) is a chlorine atom, include a alkali metal chlorides such as sodium chloride and lithium chloride, alkaline earth metal chlorides such as magnesium chloride, metal chlorides such as aluminum chloride and zinc(II) chloride, quaternary ammonium chlorides such as tetrabutylammonium chloride, organic silicon chlorides such as trimethylsilyl chloride, sulfur compounds such as thionyl chloride, phosphorus compounds such as phosphorus oxychloride, phosphorus trichloride and phosphorus pentachloride, and hydrogen chloride.
    Examples of the reagent used in the reaction, in the case where R14 in the compound (12) is a bromine atom, include alkali metal bromides such as sodium bromide, alkaline earth metal bromides such as magnesium bromide, metal bromides such as zinc(II) bromide, quaternary ammonium bromides such as tetrabutylammonium bromide, organic silicon bromides such as trimethylsilyl bromide, phosphorus compounds such as phosphorus tribromide, and hydrogen bromide.
    Examples of the reagent used in the reaction, in the case where R14 in the compound (12) is an iodine atom, include alkali metal iodides such as potassium iodide, alkaline earth metal iodides such as magnesium iodide, metal iodides such as zinc(II) iodide, quaternary ammonium iodides such as tetrabutylammonium iodide, organic silicon compounds such as trimethylsilyl iodide, and hydrogen iodide.
    Examples of the reagent used in the reaction, in the case where R14 in the compound (12) is a cyano group, include cyanides such as potassium cyanide and sodium cyanide, and organic silicon compounds such as trimethylsilyl cyanide.
    The reaction is usually performed in the presence of a solvent.
    Examples of the solvent used in the reaction include ethers such as THF, ethylene glycol dimethyl ether and MTBE, aromatic hydrocarbons such as toluene and xylene, halogenated hydrocarbons such as chlorobenzene and chloroform, esters such as butyl acetate and ethyl acetate, nitriles such as acetonitrile, acid amides such as DMF, water, and a mixture thereof.
    The used amount of the reagent is usually 1 to 10 mol per 1 mol of the compound (11).
    The reaction temperature is usually in a range of from -20 to 150°C, and the reaction time is usually in a range of from 0.1 to 24 hours.
    After completion of the reaction, the compound (12) of the present invention can be isolated by post-treatment such as extraction of the reaction mixture with an organic solvent, and drying and concentration of an organic layer. The isolated compound (12) of the present invention can be further purified by chromatography, recrystallization or the like.
    • (Production process 7)
  • Figure imgb0008
     In the formulae, X1 and X2 are as defined above, A3 is A2-Cy and Cy represents a C3-C6 cycloalkyl group substituted with at least one hydroxyl group, and A4 is A2-Cy and Cy represents a C3-C6 cycloalkyl group substituted with at least one halogen atom.
    The compound (14) of the present invention may be produced by reacting the compound (13) and the following halogenating reagent.
    Examples of the halogenating reagent used in the reaction, in the case where the halogen atom of the C3-C6 cycloalkyl group substituted with at least one halogen atom in the compound (14) of the present invention is a fluorine atom, include fluorinating agents such as 2,2-difluoro-1,3-dimethylimidazolidine, hydrogen fluoride pyridine complex, diethyl(1,2,3,3,3-pentafluoro-1-propenyl)amine, di(2-methoxyethyl)sulfur trifluoride, diethylaminosulfur trifluoride, tetrafluorosulfur and N-(2-chloro-1,1,2-trifluoroethyl)diethylamine.
    Examples of the halogenating reagent used in the reaction, in the case where the halogen atom of the C3-C6 cycloalkyl group substituted with at least one halogen atom in the compound (14) of the present invention is a chlorine atom, include chlorinating agents such as thionyl chloride, phosphorus oxychloride, phosphorus trichloride, phosphorus pentachloride and phosgene.
    Examples of the halogenating reagent used in the reaction, in the case where the halogen atom of the C3-C6 cycloalkyl group substituted with at least one halogen atom in the compound (14) of the present invention is a bromine atom, include brominating agents such as phosphorus tribromide.
    Examples of a solvent used in the reaction include ethers such as THF, ethylene glycol dimethyl ether and MTBE, aromatic hydrocarbons such as toluene and xylene, halogenated hydrocarbons such as chlorobenzene and chloroform, nitriles such as acetonitrile, and a mixture thereof.
    The used amount of the reagent is usually 1 to 10 mol per 1 mol of the compound (13) of the present invention.
    The reaction temperature is usually in a range of from -78 to 150°C, and the reaction time is usually in a range of from 0.1 to 24 hours.
    After completion of the reaction, the compound (14) of the present invention can be isolated by post-treatment such as extraction of the reaction mixture with an organic solvent, and drying and concentration of an organic layer. The isolated compound (14) of the present invention can be further purified by chromatography, recrystallization or the like.
  • A part of intermediates used for production of the compound of the present invention are commercially available or disclosed in known literatures. Such intermediates can be produced, for example, by the following processes.
    • (Intermediate production process 1)
  • The compound (3) and the compound (4) can be produced by the process shown in the following scheme.
    Figure imgb0009
    Figure imgb0010
     In the formulae, X1 and X2 are as defined above.
    • Step (i-1)
  • The compound (M2) can be produced by reacting the compound (M1) and propargyl bromide in the presence of a base.
    The reaction is usually performed in the presence of a solvent.
    Examples of the solvent used in the reaction include acid amides such as DMF and sulfoxides such as DMSO.
    Examples of the base used in the reaction include alkali metal carbonates such as sodium carbonate, potassium carbonate and cesium carbonate, and alkali metal hydroxides such as sodium hydroxide.
    The used amount of propargyl bromide is usually 2 to 5 mol per 1 mol of the compound (M1). The used amount of the base is usually 2 to 5 mol per 1 mol of the compound (M1).
    The reaction temperature is usually in a range of from 0 to 140°C, and the reaction time is usually in a range of from 0.5 to 24 hours.
    After completion of the reaction, the compound (M2) can be isolated by post-treatment such as extraction of the reaction mixture with an organic solvent, and drying and concentration of an organic layer. The isolated compound (M2) can be further purified by chromatography, recrystallization or the like.
    • Step (i-2)
  • The compound (3) can be produced by hydrolyzing the compound (M2) in the presence of a base.
    The reaction is usually performed in the presence of a solvent.
    Examples of the base used in the reaction include alkali metal hydroxides such as sodium hydroxide and potassium hydroxide.
    Examples of the solvent used in the reaction include ethers such as tetrahydrofuran, ethylene glycol dimethyl ether and tert-butyl methyl ether, alcohols such as methanol and ethanol, water, and a mixture thereof.
    The used amount of the base is usually 1 to 10 mol per 1 mol of the compound (M2).
    The reaction temperature is usually in a range of from 0 to 120°C, and the reaction time is usually in a range of from 0.5 to 24 hours.
    After completion of the reaction, the reaction solution is made acidic. In the case where a solid is precipitated, the compound (3) can be isolated by filtration. In the case where a solid is not precipitated, the compound (3) can be isolated by post-treatment such as extraction of the reaction mixture with an organic solvent, and drying and concentration of an organic layer. The isolated compound (3) can be further purified by chromatography, recrystallization or the like.
    • Step (i-3)
  • The compound (4) can be produced by reacting the compound (3) and thionyl chloride.
    The reaction is usually performed in the presence of a solvent.
    Examples of the solvent used in the reaction include aliphatic hydrocarbons such as hexane, heptane and octane, aromatic hydrocarbons such as toluene and xylene, nitriles such as acetonitrile, halogenated hydrocarbons such as chlorobenzene, acid amides such as DMF, and a mixture thereof.
    The used amount of thionyl chloride is usually 1 to 2 mol per 1 mol of the compound (3).
    The reaction temperature is usually in a range of from 20 to 120°C, and the reaction time is usually in a range of from 0.1 to 24 hours.
    After completion of the reaction, the compound (4) can be isolated by post-treatment such as concentration of the reaction mixture. The isolated compound (4) can be further purified by chromatography, recrystallization or the like.
    • (Intermediate production process 2)
  • The compound (10) can be produced by the process shown in the following scheme.
    Figure imgb0011
     In the formulae, A, X1 and X2 are as defined above.
    • Step (ii-1)
  • The compound (M3) can be produced by reacting the compound (M1) and benzyl bromide in the presence of a base.
    The reaction is usually performed in the presence of a solvent.
    Examples of the solvent used in the reaction include acid amides such as DMF, and sulfoxides such as DMSO.
    Examples of the base used in the reaction include alkali metal carbonates such as sodium carbonate, potassium carbonate and cesium carbonate, and alkali metal hydroxides such as sodium hydroxide.
    The used amount of benzyl bromide is usually 2 to 5 mol per 1 mol of the compound (M1). The used amount of the base is usually 2 to 5 mol per 1 mol of the compound (M1)
    The reaction temperature is usually in a range of from 0 to 140°C, and the reaction time is usually in a range of from 0.5 to 24 hours.
    After completion of the reaction, the compound (M3) can be isolated by post-treatment such as extraction of the reaction mixture with an organic solvent, and drying and concentration of an organic layer. The isolated compound (M3) can be further purified by chromatography, recrystallization or the like.
    • Step (ii-2)
  • The compound (M4) can be produced by hydrolyzing the compound (M3) in the presence of a base.
    The reaction is usually performed in the presence of a solvent.
    Examples of the base used in the reaction include alkali metal hydroxides such as sodium hydroxide and potassium hydroxide.
    Examples of the solvent used in the reaction include ethers such as tetrahydrofuran, ethylene glycol dimethyl ether and MTBE, alcohols such as methanol and ethanol, water, and a mixture thereof.
    The used amount of the base is usually 1 to 10 mol per 1 mol of the compound (M3).
    The reaction temperature is usually in a range of from 0 to 120°C, and the reaction time is usually in a range of from 0.5 to 24 hours.
    After completion of the reaction, the reaction solution is made acidic. In the case where a solid is precipitated, the compound (M4) can be isolated by filtration. In the case where a solid is not precipitated, the compound (M4) can be isolated by post-treatment such as extraction of the reaction mixture with an organic solvent, and drying and concentration of an organic layer. The isolated compound (M4) can be further purified by chromatography, recrystallization of the like.
    • Step (ii-3)
  • The compound (M5) can be produced by reacting the compound (M4) and thionyl chloride.
    The reaction is usually performed in the presence of a solvent.
    Examples of the solvent used in the reaction include aliphatic hydrocarbons such as hexane, heptane and octane, aromatic hydrocarbons such as toluene and xylene, nitriles such as acetonitrile, halogenated hydrocarbons such as chlorobenzene, acid amides such as DMF, and a mixture thereof.
    The used amount of thionyl chloride is usually 1 to 2 mol per 1 mol of the compound (M4).
    The reaction temperature is usually in a range of from 20 to 120°C, and the reaction time is usually in a range of from 0.1 to 24 hours.
    After completion of the reaction, the compound (M5) can be isolated by post-treatment such as concentration of the reaction mixture. The isolated compound (M5) can be further purified by chromatography, recrystallization or the like.
    • Step (ii-4)
  • The compound (M6) can be produced by reacting the compound (M5) and the compound (2) in the presence of a base according to the process described in Production process 2.
    • Step (ii-5)
  • The compound (10) can be produced by reacting the compound (M6) with hydrogen in the presence of palladium carbon.
    The reaction is usually performed in the presence of a solvent.
    Examples of the solvent used in the reaction include aliphatic hydrocarbons such as hexane, heptane and octane, aromatic hydrocarbons such as toluene and xylene, alcohols such as methanol and ethanol, esters such as ethyl acetate, ethers such as THF and MTBE, water, and a mixture thereof.
    The used amount of palladium carbon is 0.01 to 0.1 mol per 1 mol of the compound (M6). The used amount of hydrogen is usually 1 to 2 mol per 1 mol of the compound (M6).
    The reaction temperature is usually in a range of from 0 to 50°C, and the reaction time is usually in a range of from 0.1 to 24 hours.
    The pressure of hydrogen used in the reaction is in a range of from normal pressure to 10 atoms.
    After completion of the reaction, the compound (10) can be isolated by post-treatment such as filtration and concentration of the reaction mixture. The isolated invented compound (10) can be further purified by chromatography, recrystallization or the like.
  • Examples of a compound represented by the formula (3):
    Figure imgb0012
     wherein X1, and X2 are as defined above, which is an intermediate for producing the compound of the present invention include the following compounds:
    • a compound of the formula (3), wherein X1 is a fluorine atom; and
    • a compound of the formula (3), wherein X1 is a methoxy group.
  • Examples of a compound represented by the formula (10) :
    Figure imgb0013
     wherein X1, X2 and A are as defined above, which is an intermediate for producing the compound of the present invention include the following compounds:
    • a compound of the formula (10), wherein X1 is a fluorine atom; and
    • a compound of the formula (10), wherein X1 is a methoxy group.
  • Examples of a compound represented by the formula (11) :
    Figure imgb0014
     wherein X1 and X2 are as defined above, which is an intermediate for producing the compound of the present invention include the following compounds:
    • a compound of the formula (11), wherein X1 is a fluorine atom; and
    • a compound of the formula (11), wherein X1 is a methoxy group.
  • Plant diseases against which the compound of the present invention exerts an excellent effect include those caused by fungi, bacteria and viruses. Specific examples of the fungi include genus Erysiphe such as wheat powdery mildew (Erysiphe graminis), genus Uncinula such as grape powdery mildew (Uncinula necator), genus Podosphaera such as apple powdery mildew (Podosphaera leucotricha), genus Sphaerotheca such as cucumber powdery mildew (Sphaerotheca cucurbitae), genus oidiopsis such as tomato powdery mildew (Oidiopsis sicula), genus Magnaporthe such as rice blast (Magnaporthe oryzae), genus Cachliobolus such as rice brown spot (Cochliobolus miyabeanus), genus Mycosphaerella such as wheat leaf blotch (Mycosphaerella graminicola), genus Pyrenophora such as barley net blotch (Pyrenophora teres), genus Stagonaspora such as wheat Glume blotch (Stagonaspara nodorum), genus Rhynchosporium such as barley scald (Rhynchosporium secalis), genus Pseudocercosporella such as wheat eyespot (Pseudocercosporella herpotrichoides), genus Gaeumannomyces such as wheat take-all (Gaeumannomyces graminis), genus Fusarium such as wheat Fusarium, head blight (Fusarium spp.), genus Microdochium such as wheat snow mold (Microdochium nivale), genus Venturia such as apple scab (Venturia inaequalis), genus Elsinoe such as grape anthracnose (Elsinoe ampelina), genus Botrytis such as cucumber gray mold (Botrytis cinerea), genus Monilinia such as peach brown rot (Monilinia fructicola), genus Phoma such as rape stem canker (Phoma lingam), genus Cladosporium such as tomato leaf mold (Cladosporium fulvum), genus Cercospora such as sugarbeet brown spot (Cercospora beticola), genus Cercosporidium such as peanut late leaf spot (Cercosporidium personatum), genus Colletotrichum such as strawberry anthracnose (Colletotrichum fragariae), genus Sclerotinia such as cucumber stem rot (Sclerotinia sclerotiorum), genus Alternaria such as apple necrotic leaf spot (Alternaria mali), genus Verticillium such as eggplant verticillium wilt (Verticillium dahliae), genus Rhizoctonia such as rice sheath blight (Rhizoctonia solani), genus Puccinia such as wheat leaf rust (Puccinia recondita), genus Phakopsora such as soybean rust (Phakopsora pachyrhizi), genus Tilletia such as wheat bunt (Tilletia caries), genus Ustilago such as barley loose smut (Ustilago nuda), genus Sclerotium such as peanut southern blight (Sclerotium rolfsii), genus Phytophthora such as potato late blight (Phytophthora infestans), genus Pseudoperonospora such as cucumber downy mildew (Pseudoperonospara cubensis), genus Peronospora such as Chinese cabbage downy mildew (Peronospora parasitica), genus Plasmopara such as grape downy mildew (Plasmopara viticola), genus Sclerophthora such as rice downy mildew (Sclerophthora macrospora), genus Pythium such as cucumber seedling damping-off (Pythium ultimum), and genus Plasmodiophora such as rapeseed clubroot (Plasmodiophora brassicae). Examples of bacteria include genus Burkholderia such as bacterial rice seedling blight (Burkholderia plantarii), genus Pseudomanas such as bacterial cucumber leaf spot (Pseudomonas syringae pv. Lachrymans), genus Ralstonia such as eggplant wilting (Ralstonia solanacearum), genus Xanthomonas such as Asiatic citrus canker (Xanthomonas citiri), and genus Erwinia such as Chinese cabbage bacterial soft rot (Erwinia carotovora). Examples of viruses include Tobacco mosaic virus and Cucumber mosaic virus. However, the sterilizing spectra should not be limited thereto in any cases.
  • The plant disease controlling agent of the present invention can be the compound of the present invention itself, but usually it is used in the form of formulations such as emulsifiable concentrates, wettable powders, granular wettable powders, flowable formulations, dusts, and granules produced by mixing it with solid carriers, liquid carriers, surface active agents and other auxiliary agents for formulation. These formulations usually contain the compound of the present invention in an amount of 0.1 to 90 % by weight.
  • Examples of the solid carriers used in the formulations include fine powders or particles of minerals such as kaolin clay, attapulgite clay, bentonite, montmorillonite, acid clay, pyrophyllite, talc, diatomaceous earth, and calcite; natural organic substances such as corncob powder, and walnut shell flour; synthetic organic substances such as urea; salts such as calcium carbonate, and ammonium sulfate; and synthetic inorganic substances such as synthetic hydrated silicon oxide. Examples of the liquid carriers include aromatic hydrocarbons such as xylene, alkylbenzene and methylnaphthalene; alcohols such as 2-propanol, ethylene glycol, propylene glycol and cellosolve; ketones such as acetone, cyclohexanone and isophorone; vegetable oils such as soybean oil and cottonseed oil; petroleum aliphatic hydrocarbons; esters; and dimethyl sulfoxide, acetonitrile and water.
  • Examples of the surfactant include anionic surfactants such as alkyl sulfate, alkyl aryl sulfonate, dialkyl sulfosuccinate, polyoxyethylene alkyl aryl ether phosphate, ligninsulfonate and a naphthalenesulfonate formaldehyde polycondensate; and nonionic surfactants such as polyoxyethylene alkyl aryl ether, a polyoxyethylene alkyl polyoxypropylene block copolymer and sorbitan fatty acid ester.
  • Examples of the auxiliary agent for formulation include water-soluble polymers such as polyvinyl alcohol and polyvinyl pyrrolidone; polysaccharides such as gum Arabic, alginic acid and a salt thereof, CMC (carboxymethyl cellulose) and xanthan gum; inorganic substances such as aluminum magnesium silicate, and alumina sol; preservatives; colorants; PAP (acidic isopropyl phosphate); and stabilizers such as BHT.
  • The plant disease controlling agent of the present invention is used for treating plants to protect the plants from plant diseases, and is also used for treating soil to protect plants growing in the soil from plant diseases.
  • When the plant disease controlling agent of the present invention is used by subjecting plants to a foliage treatment used by treating soil, its application amount varies depending upon the kind of crops as plants to be protected, the kind of diseases to be controlled, severity of diseases, form of the formulation, time of application, weather conditions and the like. The total amount of the compound of the present invention is usually within a range of from 1 to 5,000 g, and preferably from 5 to 1,000 g per 10,000 m2.
  • Emulsifiable concentrates, wettable powders and flowable formulations are usually used for treatment by spraying after dilution with water. In this case, the concentration of the compound of the present invention is usually within a range of from 0.0001 to 3% by weight, and preferably from 0.0005 to 1% by weight. Dusts and granules are usually used for a treatment without being diluted.
  • The plant disease controlling agent of the present invention can be used by a treating method such as seed disinfection. Examples of the method include a method of immersing seeds of plants in the plant disease controlling agent of the present invention in which the concentration of the compound of the present invention is adjusted within a range of 1 to 1,000 ppm, a method of spraying or smearing the plant disease controlling agent of the present invention in which the concentration of the compound of the present invention is adjusted within a range of from 1 to 1,000 ppm, on seeds of plants, and a method of dust coating of seeds of plants using the plant diseases controlling agent of the present invention.
  • The method for controlling a plant disease of the present invention is usually carried out by treating a plant in which onset of diseases is presumed, or soil where the plant is growing, with an effective amount of the plant disease controlling agent of the present invention, and/or treating a plant in which onset of diseases has been confirmed, or the soil where the plants are growing.
  • The plant disease controlling agent of the present invention can be used as a controlling agent for plant diseases in crop lands such as upland fields, paddy fields, lawn, and orchards, etc. The plant disease controlling agent can control plant diseases in crop lands where the following "crops" or the like are cultivated.
  • Field crops: corn, rice, wheat, barley, rye, oat, sorghum, cotton, soybean, peanut, buckwheat, beet, rape, sunflower, sugarcane, tobacco, etc.
    Vegetables: solanaceae (e.g. eggplant, tomato, green pepper, pepper and potato), Cucurbitaceae (e.g. cucumber, pumpkin, zucchini, watermelon and melon), Cruciferae (e.g. Japanese radish, turnip, horseradish, kohlrabi, Chinese cabbage, cabbage, leaf mustard, broccoli and cauliflower), Compositae (e.g. edible burdock, garland chrysanthemum, globe artichoke and lettuce), Liliacede (e.g., Welsh onion, onion, garlic and asparagus), Umbelliferae (e.g. carrot, parsley, celery and pastinaca), Chenopodiaceae (e.g. spinach and chard), Lamiaceae (e.g. perilla, mint and basil), strawberry, sweet potato, Chinese yam, taro, etc.
    Flowers and ornament plants.
    Ornamental foliage plants.
    Fruit trees: pomaceous fruits (e.g. apple, pear, Japanese pear, Chinese quince and quince), stone fruits (e.g. peach, plum, nectarine, Japanese apricot, cherry, apricot and prune), citrus fruits (e.g. satsuma mandarin, orange, lemon, lime and grapefruit), nut trees (e.g. chestnut, walnut, hazel, almond, pistachio, cashew nut and macadamia nut), berries (blueberry, cranberry, blackberry and raspberry), grape, Japanese persimmon, olive, loquat, banana, coffee, date palm, coconut palm, etc.
    Trees other than fruit trees: tea, mulberry, flowering trees and shrubs, street trees (e.g. Japanese ash, birch, flowering dogwood, blue gum, ginkgo, lilac, maple, oak, poplar, Chinese redbud, Formosa sweet gum, plane tree, zelkova, Japanese arborvitae, fir, Japanese hemlock, needle juniper, pine, Japanese spruce and Japanese yew), etc.
  • The above-described "crops" include crops having resistance to herbicides such as HPPD inhibitors (e.g. isoxaflutole), ALS inhibitors (e.g. imazethapyr and thifensulfuron-methyl), EPSP synthetase inhibitors, glutamine synthetase inhibitors, bromoxynil, etc. which has been imparted by a classic breeding method or a genetic recombination technology.
  • Examples of the "crops" having the resistance imparted by the classic breeding method include Glearfield® canola resistnt to imidazolinone herbicides (e.g. imazethapyr) and STS soybean resistant to sulfonylurea ALS inhibition type herbicides (e.g. thifensulfuron-methyl). As crops having the resistance imparted by the genetic recombination technology, corn cultivars resistant to glyphosate and glufosinate are exemplified and are already on the market under the trade names of RoundupReady® and LibertyLink®.
  • The above-described "crops" include crops which have been enabled by the genetic recombination technology to synthesize a selective toxin known in the case of, for example Bacillus.
    Examples of toxin produced in such genetically modified plants include insecticidal proteins derived from Bacillus cereus and Bacillus popilliae; insecticidal proteins such as δ-endotoxins (e.g. Cry1Ab, Cry1Ac, Cry1F, Cry1Fa2, Cry2Ab, Cry3A, Cry3Bb1 and Cry9C), VIP 1, VIP 2, VIP 3, VIP 3A, etc., which are derived from Bacillus thuringiensis; toxins derived from nematodes; toxins produced by animals, such as scorpion toxin, spider toxin, bee toxin, insect-specific neurotoxins, etc.; filamentous fungi toxins; plant lectins; agglutinin; protease inhibitors such as trypsin inhibitors, serine protease inhibitors, patatin, cystatin, papain inhibitors, etc.; ribosome-inactivating proteins (RIPs) such as ricin, corn-RIP, abrin, rufin, sapolin, briodin, etc.; steroid metabolic enzymes such as 3-hydroxysteroid oxidase, ecdysteroid-UDP-glucosyltransferase, cholesterol oxidase, etc.; ecdysone inhibitors; HMG-COA reductase; ion channel inhibitors such as sodium channel inhibitors, calcium channel inhibitors, etc.; juvenile hormone esterase; diuretic hormone receptors; stilbene synthetase; bibenzyl synthetase; chitinase; and glucanase.
  • The toxin produced in such genetically engineered crops also include hybrid toxins, partly deficient toxins and modified toxins of insecticidal proteins such as 5-endotoxin proteins (e.g. Cry1Ab, Cry1Ac, Cry1F, Cry1Fa2, Cry2Ab, Cry3A, Cry3Bb1 and Cry9C), VIP 1, VIP 2, VIP 3, VIP 3A, etc. The hybrid toxins are produced by a novel combination of the different domains of suchproteins by adoping a recombination technology. As the partly deficient toxin, Cry1Ab deficient in a part of the amino acid sequence is known. In the modified toxins, one or more amino acids of a natural toxin have been replaced.
    Examples of such toxins and genetically modified plants capable of synthesizing such toxins are described in EP-A-0 374 753 , WO 93/07278 , WO 95/34656 , EP-A-0 427 529 , EP-A-451 878 , WO 03/052073 , etc.
    The toxins contained in such genetically engineered plants impart resistance to insect pests of Coleoptera, insect pests of Diptera and insect pests of Lepidoptera to the plants.
  • Genetically engineered plants containing one or more insecticidal insect-resistance genes and capable of producing one or more toxins have already been known, and some of them are on the market.. Examples of such genetically modified plants include YieldGard® (a corn cultivar capable of producing Cry1Ab toxin), YieldGard Rootwarm® (a corn cultivar capable of producing Cry3Bb1 toxin), YieldGard Plus® (a corn cultivar capable of producing Cry1Ab and Cry3Bb1 toxins), Herculex I® (a corn cultivar capable of producing phosphinotrysin N-acetyltransferase (PAT) for imparting resistance to Cry1Fa2 toxin and Glyfosinate), NuCOTN33B (a cotton cultivar capable of producing Cry1Ac toxin), Bollgard I® (a cotton cultivar capable of producing Cry1Ac toxin), Bollgard II® (a cotton cultivar capable of producing Cry1Ac and Cry2Ab toxins), VIPCOT® (a cotton cultivar capable of producing VIP toxin), NewLeaf® (a potato cultivar capable of producing Cry3A toxin), NatureGard®, Agrisure®, GT Advantage (GA21 glyphosate resistant properties), Agrisure® CB Advantage (Bt11 corn borer (CB) properties), and Protecta®.
  • The above-mentioned "crops" also include crops having an ability to produce an anti-pathogenic substance having a selective action which has been imparted by a gene recombination technology.
    As examples of the anti-pathogenic substance, PR proteins and the like are known (PRPs, EP-A-0 392 225 ). Such anti-pathogenic substances and genetically engineered plants capable of producing them are described in EP-A-0 392 225 , WO 95/33818 , EP-A-0 353 191 , and the like.
    Examples of such anti-pathogenic substances produced by the genetically modified plants include ion channel inhibitors such as sodium channel inhibitors, calcium channel inhibitors (for example, KP1, KP4 and KP6 toxins produced by viruses are known), etc.; stilbene synthase; bibenzyl synthase; chitinase; glucanase; PR proteins; and anti-pathogenic substances produced by microorganisms such as peptide antibiotics, antibiotics having a heterocyclic ring, protein factors concerned in resistance to plant diseases (which are called plant-disease-resistant genes and are described in WO 03/000906 ), etc.
  • It is also possible to use the plant disease controlling agent of the present invention after mixing with other fungicides, insecticides, acaricides, nematocides, herbicides, plant growth regulators, fertilizers or soil conditioners, or to use the agent without mixing them. Examples of the active ingredients of the plant disease controlling agent include chlorothalonil, fluazinam, dichlofluanid, fosetyl-Al, cyclic imide derivatives (e.g., captan, captafol, folpet, etc.), dithiocarbamate derivatives (e.g., maneb, mancozeb, thiuram, ziram, zineb, propineb, etc.), inorganic or organic copper derivatives (e.g., basic copper sulfate, basic copper chloride, copper hydroxide, oxine-copper, etc.), acylalanine derivatives (e.g., metalaxyl, furalaxyl, ofurace, cyprofuram, benalaxyl, oxadixyl, etc.), strobilurine like compound (e.g., kresoxim-methyl, azoxystrobin, trifloxystrobin, picoxystrobin, pyraclostrobin, fluoxastrobin, metominostrobin, orysastrobin, enestrobin, dimoxystrobin, etc.), anilinopyrimidine derivatives (e.g., cyprodinil, pyrimethanil, mepanipyrim, etc.), phenyl pyrrole derivatives (e.g., fenpiclonil, fludioxonil, etc.), imide derivatives (e.g., procymidone, iprodione, vinclozolin, etc.), benzimidazole derivatives (e.g., carbendazim, benomyl, thiabendazole, thiophanate methyl, etc.), amine derivatives (e.g., fenpropimorph, tridemorph, fenpropidin, spiroxamine, etc.), azole derivatives (e.g., propiconazole, triadimenol, prochloraz, penconazole, tebuconazole, flusilazole, diniconazole, bromuconazole, epoxiconazole, difenoconazole, cyproconazole, metconazole, triflumizole, tetraconazole, myclobutanil, fenbuconazole, hexaconazole, fluquinconazole, triticonazole, bitertanol, imazalil, flutriafol, ipconazole, pefurazoate, prothioconazole, etc.), triforine, pyrifenox, fenarimol, propamocarb, cymoxanil, dimethomorph, flumorph, famoxadone, fenamidone, pyribencarb, iprovalicarb, benthiavalicarb, mandipropamid, cyazofamid, amisulbrom, zoxamide, ethaboxam, boscalid, penthiopyrad, fluopyram, bixafen, carboxin, oxycarboxin, thifluzamide, flutolanil, mepronil, furametpyr, pencycuron, hymexazol, etridiazole, ferimzone, silthiofam, blasticidin S, kasugamycin, streptomycin, pyrazophos, iprobenfos, edifenphos, isoprothiolane, fthalide, pyroquilon, tricyclazole, carpropamid, diclocymet, fenoxanil, probenazole, tiadinil, isotianil, iminoctadine, guazatine, tolnifanide, tolclophos-methyl, fenhexamid, polyoxin B, quinoxyfen, proquinazid, metrafenone, cyflufenamid, diethofencarb, fluopicolide and acibenzolar-S-methyl.
    • Examples
  • Hereinafter, the present invention will be described in more detail by way of Production Examples, Formulation Examples and Test Examples which the present invention is not limited to.
    First, Production Examples of the compound of the present invention will be described.
    • Production Example 1
  • To a mixture of 1 ml of ethyl acetate and 0.24 g of 3-chloro-5-fluoro-4-(2-propynyloxy)benzoyl chloride was added dropwise a mixture of 0.13 g of cyclohexylmethylamine, 0.2 ml of triethylamine and 1 ml of ethyl acetate under ice-cooling, and the mixture was stirred at room temperature for 4 hours. The reaction mixture was concentrated under reduced pressure. The residue was subjected to silica gel column chromatography, and 0.25 g of N-(cyclohexylmethyl)-3-chloro-5-fluoro-4-(2-propynyloxy)benzamide (hereinafter, referred to as a compound 1 of the present invention) was obtained.
    The compound 1 of the present invention
    Figure imgb0015
     1H-NMR (CDCl3) δ: 0.97-1.04 (2H, m), 1.15-1.30 (3H, m), 1.57-1.78 (6H, m), 2.51 (1H, t, J = 2.4 Hz), 3.28 (2H, dd, J = 6.6, 6.3 Hz), 4.88 (2H, d, J = 2.4 Hz), 6.03-6.06 (1H, m), 7.47 (1H, dd, J = 11.0, 1.9 Hz), 7.56 (1H, dd, J = 2.1, 1.9 Hz).
    • Production Example 2
  • N-(2-methylcyclohexyl)-3-chloro-5-fluoro-4-(2-propynyloxy)benzamide (hereinafter, referred to as a compound 2 of the present invention) was obtained according to a process described in Production Example 1 except that 2-methylcyclohexylamine was used in place of cyclohexylmethylamine.
    The compound 2 of the present invention
    Figure imgb0016
     1H-NMR (CDCl3) δ: 0.93 (0.8H, d, J = 6.8 Hz), 0.97 (2.2H, d, J = 6.3 Hz), 1.09-1.83 (8.0H, m), 1.93-2.07 (1.0H, m), 2.51-2.52 (1.0H, m), 3.63-3.72 (0.7H, m), 4.21-4.25 (0.3H, m), 4.88 (2.0H, t, J = 2.3 Hz), 5.72 (0.7H, d, J = 8.3 Hz), 5.98 (0.3H, d, J = 7.8 Hz), 7.44-7.49 (1.0H, m), 7.55-7.56 (1.0H, m).
    • Production Example 3
  • N-(2-methylcyclopentyl)-3-chloro-5-fluoro-4-(2-propynyloxy)benzamide (hereinafter, referred to as a compound 3 of the present invention) was obtained according to a process described in Production Example 1, except that 2-methylcyclopentylamine was used in place of cyclohexylmethylamine.
    The compound 3 of the present invention
    Figure imgb0017
     1H-NMR (CDCl3 ) δ: 0.94 (2.0H d, J = 7.1 Hz), 1.08 (1.0H, d, J = 6.6 Hz), 1.25-2.30 (7.0H, m), 2.50-2.52 (1.0H, m), 3.90-3.97 (0.4H, m), 4.38-4.45 (0.6H, m), 4.88-4.91 (2.0H, m), 5.83-5.84 (1.0H, m), 7.44-7.49 (1.0H, m), 7.54-7.56 (1.0H, m).
    • Production Example 4
  • N-(1-hydroxycyclohexyl)methyl-3-chloro-5-fluoro-4-(2-propynyloxy)benzamide (hereinafter, referred to as a compound 4 of the present invention) was obtained according to a process described in Production Example 1 except that 1-(1-hydroxycyclohexyl)methylamine hydrochloride was used in place of cyclohexylmethylamine.
    The compound 4 of the present invention
    Figure imgb0018
     1H-NMR (CDCl3) δ: 1.34-1.60 (10H, m), 2.03 (1H, s), 2.52 (1H, t, J = 2.4 Hz), 3.47 (2H, d, J = 5.8 Hz), 4.89 (2H, d, J = 2.4 Hz), 6.54-6.56 (1H, m), 7.51 (1H, dd, J = 11.0, 2.1 Hz), 7.62 (1H, dd, J = 2.1, 1.6 Hz).
    • Production Example 5
  • N-(cyclohexylmethyl)-3-methoxy-5-methyl-4-(2-propynyloxy)benzamide (hereinafter, referred to as a compound 5 of the present invention) was obtained according to a process described in Production Example 1 except that 3-methoxy-5-methyl-4-(2-propynyloxy)benzoyl chloride was used in place of 3-chloro-5-fluoro-4-(2-propynyloxy)benzoyl chloride.
    The compound 5 of the present invention
    Figure imgb0019
     1H-NMR (CDCl3 ) δ: 0.99-1.04 (2H, m), 1.16-1.27 (3H, m), 1.55-1.80 (6H, m), 2.35 (3H, s), 2.42 (1H, t, J = 2.4 Hz), 3.29 (2H, t, J = 6.5 Hz), 3.90 (3H, s), 4.76 (2H, d, J = 2.4 Hz), 6.08-6.10 (1H, m), 7.06 (1H, s), 7.29 (1H, s).
    • Production Example 6
  • N-(2-methylcyclohexyl)-3-methoxy-5-methyl-4-(2-propynyloxy)benzamide (hereinafter, referred to as a compound 6 of the present invention) was obtained according to a process described in Production Example 1 except that 2-methylcyclohexylamine and 3-methoxy-5-methyl-4-(2-propynyloxy)benzoyl chloride were used in place of cyclohexylmethylamine and 3-chloro-5-fluoro-4-(2-propynyloxy)benzoyl chloride respectively.
    The compound 6 of the present invention
    Figure imgb0020
     1H-NMR (CDCl3) δ: 0.94 (1.0H, d, J = 7.1 Hz), 0.99 (2.0H, d, J = 6.6 Hz), 1.13-1.82 (8.0H, m), 1.93-2.07 (1.0H, m), 2.35 (2.0H, s), 2.37 (1.0H, s), 2.42 (1.0H, t, J = 2.4 Hz), 3.64-3.74 (0.7H, m), 3.90-3.90 (3.0H, m), 4.22-4.28 (0.3H, m), 4.76-4.77 (2.0H, m), 5.77 (0.7H, d, J = 9.3 Hz), 6.06 (0.3H, d, J = 8.8 Hz), 7.04-7.06 (1.0H, m), 7.29-7.30 (1.0H, m).
    • Production Example 7
  • N-(1-hydroxycyclohexyl)methyl-3-methoxy-5-methyl-4-(2-propynyloxy)benzamide (hereinafter, referred to as a compound 7 of the present invention) was obtained according to a process described in Production Example 1 except that 1-(1-hydroxycyclohexyl)methylamine hydrochloride and 3-methoxy-5-methyl-4-(2-propynyloxy)benzoyl chloride were used in place of cyclohexylmethylamine and 3-chloro-5-fluoro-4-(2-propynyloxy)benzoyl chloride respectively.
    The compound 7 of the present invention
    Figure imgb0021
     1H-NMR (CDCl3) δ: 1.34-1.62 (10H, m), 1.77 (1H, s), 2.33 (3H, s), 2.43 (1H, t, J = 2.4 Hz), 3.47 (2H, d, J = 5.8 Hz), 3.88 (3H, s), 4.76 (2H, d, J = 2.4 Hz), 6.60-6.63 (1H, m), 7.14 (1H, s), 7.30 (1H, s).
    • Production Example 8
  • Figure imgb0022
    Figure imgb0023
     To a solution of 7.0 g of N-(cyalahexylmethyl)-3,4-difluorobenzamide and 3.6 g of benzyl alcohol in 70 ml of DMF was added 1.3 g of 60% sodium hydride (oily) at room temperature, and the mixture was stirred at 80°C for 4 hours. The reaction mixture was added to water. The resulting solid was collected by filtration, and washed with hexane, and a residue was obtained.
    The residue was added to a mixture of 100 ml of ethyl acetate and 10 ml of methanol, and 100mg of 10% palladium carbon was added thereto. A reaction was performed under hydrogen atmosphere at a normal pressure for 6 hours. The reaction mixture was filtered with Celite. The filtrate was concentrated under reduced pressure, and the resulting residue was washed with MTBE, and 5.5 g of a product was obtained.
    • N-(cyclohexylmethyl)-3-fluoro-4-hydroxybenzamide
  • 1H-NMR (CDCl3) δ: 0.93-1.29 (5H, m), 1.52-1.80 (6H, m), 3.25 (2H, dd, J = 6.3, 6.3 Hz), 6.55-6.60 (1H, m), 6.98 (1H, t, J = 8.5 Hz), 7.43 (1H, dd, J = 8.4, 2.1 Hz), 7.56 (1H, dd, J = 11.8, 2.1 Hz), 9.41 (1H, s).
  • Figure imgb0024
     To 5 ml of concentrated sulfuric acid was added 0.50 g of N-(cyclohexylmethyl)-3-fluoro-4-hydroxybenzamide, and 0.20 g of 69% nitric acid was added thereto dropwise under ice-cooling. The mixture was stirred for 30 minutes. The reaction mixture was added to water. The resulting solid was collected by filtration, and dried, and a residue was obtained.
    To a solution of the residue, 0.63 g of triphenylphosphine and 0.13 g of propargyl alcohol in 15 ml of THF was added dropwise 1.1 g of a solution (40%) of diethyl azodicarboxylate in toluene at room temperature. The mixture was stirred at room temperature for 4 hours. The reaction mixture was concentrated under reduced pressure, and the residue was subjected to silica gel column chromatography, and 0.40 g of N-(cyclohexylmethyl)-3-fluoro-5-nitro-4-(2-propynyloxy)benzamide (hereinafter, referred to as a compound 8 of the present invention) was obtained.
    The compound 8 of the present invention
    Figure imgb0025
     1H-NMR (CDCl3) δ: 0.95-1.30 (5H, m), 1.54-1.79 (6H, m), 2.56 (1H, t, J = 2.4 Hz), 3.31 (2H, dd, J = 6.5, 6.5 Hz), 4.97 (2H, d, J = 2.4 Hz), 6.21-6.26 (1H, m), 7.86 (1H, dd, J = 11.1, 2.1 Hz), 7.98 (1H, dd, J = 1.7, 2.1 Hz).
  • The following Reference Production Examples show production of intermediates for producing the compound of the present invention.
    • Reference Production Example 1
  • To 80 ml of DMF were added 7.9 g of 3-chloro-4,5-difluorobenzoic acid, 5.9 g of propargyl bromide and 6.8 g of potassium carbonate, and the mixture was stirred at room temperature for 12 hours and then at 80°C for 1 hour. The reaction mixture was allowed to cool to near room temperature, and ethyl acetate was added thereto, followed by filtration through Celite. To the filtrate were added sequentially water and diluted hydrochloric acid, followed by extraction with ethyl acetate. The organic layer was dried over magnesium sulfate, and then concentrated under reduced pressure, and 9.0 g of 2-propynyl 3-chloro-4,5-difluorobenzoate was obtained.
    • 2-Propynyl 3-chloro-4,5-difluorobenzoate
  • Figure imgb0026
     1H-NMR (CDCl3 ) δ: 2.56 (1H, t, J = 2.6 Hz), 4.93 (2H, d, J = 2.4 Hz), 7.81 (1H, ddd, J = 9.9, 6.8, 2.1 Hz), 7.94 (1H, ddd, J = 6.0, 2.1, 1.9 Hz).
  • To a solution of 9.0 g of 2-propynyl 3-chloro-4,5-difluorobenzoate and 2.9 g of propargyl alcohol in 50 ml of DMF was added 1.7 g of 60% sodium hydride (oily) at 0°C, and the mixture was stirred at 0°C for 30 minutes and then at room temperature for 1 hour. To the reaction mixture was added water, followed by extraction with ethyl acetate. The organic layer was dried over magnesium sulfate, and then concentrated under reduced pressure. The residue was subjected to silica gel column chromatography, and 5.3 g of 2-propynyl 3-chloro-5-fluoro-4-(2-propynyloxy)benzoate was obtained.
    • 2-Propynyl 3-chloro-5-fluoro-4-(2-propynyloxy)benzoate
  • Figure imgb0027
     1H-NMR (CDCl3) δ: 2.53 (1H, t, J = 2.4 Hz), 2.54 (1H, t, J = 2.4 Hz), 4.91-4.93 (4H, m), 7.74 (1H, dd, J = 11.1, 2.0 Hz), 7.92 (1H, dd, J = 2.0, 1.8 Hz).
  • To a mixed solution of 20 ml of ethanol, 10 ml of tetrahydrofuran, 10 ml of water and 1.8 g of sodium hydroxide was added 5.0 g of 2-propynyl 3-chloro-5-fluoro-4-(2-propynyloxy)benzoate, followed by stirring at room temperature for 2 hours. The reaction mixture was concentrated under reduced pressure. The residue was made acidic by addition of hydrochloric acid. Then, a precipitated solid was collected by filtration, and 4.5 g of 3-chlorc-5-fluorc-4-(2-propynyloxy)benzoic acid was obtained.
    • 3-Chloro-5-fluoro-4-(2-propynyloxy)benzoic acid
  • Figure imgb0028
     1H-NMR (CDCl3) δ: 2.54 (1H, t, J = 2.4 Hz), 4.94 (2H, d, J = 2.4 Hz), 7.77 (1H, dd, J = 11.0, 1.8 Hz), 7.96 (1H, dd, J = 1.9, 1.8 Hz).
  • To 20 ml of toluene were added 3.0 g of 3-chloro-5-fluoro-4-(2-propynyloxy)benzoic acid, 1.0 ml of thionyl chloride and 10 mg of DMF, followed by heating to reflux for 4 hours. The reaction mixture was allowed to cool to near room temperature and then concentrated under reduced pressure, and 2.4 g of 3-chloro-5-fluoro-4-(2-propynyloxy)benzoyl chloride was obtained. 3-Chloro-5-fluoro-4-(2-propynyloxy)benzoyl chloride
    Figure imgb0029
     1H-NMR (CDCl3) δ: 2.55 (1H, t, J = 2.4 Hz), 4.99-5.00 (2H, m), 7.81 (1H, dd, J = 11.2, 2.2 Hz), 8.00 (1H, dd, J = 2.2, 1.4 Hz).
    • Reference Production Example 2
  • To 50 ml of DMF were added 4.4 g of 4-hydroxy-3-methoxy-5-methylbenzoic acid, 6.3 g of propargyl bromide and 7.3 g of potassium carbonate, and the mixture was stirred at room temperature for 1 hour and then at 80°C for 1 hour. To the reaction mixture was added ethyl acetate, followed by filtration through Celite. To the filtrate were added sequentially water and diluted hydrochloric acid, followed by extraction with ethyl acetate. The organic layer was dried over magnesium sulfate, and then concentrated under reduced pressure. The residue was subjected to silica gel column chromatography, and 3.2 g of 2-propynyl 3-methoxy-5-m-ethyl-4-(2-propynyloxy)benzoate was obtained.
    • 2-Propynyl 3-methoxy-5-methyl-4-(2-propynyloxy)benzoate
  • Figure imgb0030
     1H-NMR (CDCl3) δ: 2.35 (3H, s), 2.43 (1H, t, J = 2.4 Hz), 2.51 (1H, t, J = 2.4 Hz), 3.90 (3H, s), 4.80 (2H, d, J = 2.4 Hz), 4.90 (2H, d, J = 2.4 Hz), 7.46 (1H, d, J = 2.0 Hz), 7.56 (1H, dd, J = 2.0, 0.7 Hz).
  • To a mixed solution of 20 ml of ethanol, 10 ml of tetrahydrofuran, 10ml of water and 1.2 g of sodium hydroxide was added 5.0 g of 2-propynyl 3-methoxy-5-methyl-4-(2-propynyloxy)benzoate, and the mixture was stirred at room temperature for 2 hours. The reaction mixture was concentrated under reduced pressure. The residue was made acidic by addition of hydrochloric acid. Then, a precipitated solid was collected by filtration, and 2.2 g of 3-methoxy-5-methyl-4-(2-propynyloxy)benzoic acid was obtained.
    • 3-Methoxy-5-methyl-4-(2-propynyloxy)benzoic acid
  • Figure imgb0031
     1H-NMR (CDCl3) δ: 2.37 (3H, s), 2.44 (1H, t, J = 2.3 Hz), 3.92 (3H, s), 4.82 (2H, d, J = 2.2 Hz), 7.50 (1H, s), 7.61 (1H, s).
  • To 20 ml of toluene were added 1.1 g of 3-methoxy-5-methyl-4-(2-propynyloxy)benzoic acid, 0.5 ml of thionyl chloride and 10 mg of DMF, and the mixture was heated to reflux for 4 hours. The reaction mixture was concentrated under reduced pressure, and 1.0 g of 3-methoxy-5-methyl-4-(2-propynyloxy)benzoyl chloride was obtained. 3-Methoxy-5-methyl-4-(2-propynyloxy)benzoyl chloride
    Figure imgb0032
    Figure imgb0033
     1H-NMR (CDCl3) δ: 2.37 (3H, s), 2.45-2.45 (1H, m), 3.92 (3H, s), 4.86 (2H, d, J = 2.4 Hz), 7.50-7.50 (1H, m), 7.66-7.67 (1H, m).
  • Then, Formulation Examples are shown. The term "part(s)" represents part(s) by weight.
    • Formulation Example 1
  • 50 parts of each of the compounds 1 to 8 of the present invention, 3 parts of calcium ligninsulfonate, 2 parts of magnesium laurylsulfate and 45 parts of synthetic hydrated silica are pulverized and mixed well to give a wettable powder of each compound.
    • Formulation Example 2
  • 20 parts of each of the compounds 1 to 8 of the present invention and 1.5 parts of sorbitan trioleate are mixed with 28.5 parts of an aqueous solution containing 2 parts of polyvinyl alcohol, and wet-pulverized finely. To the obtained mixture, 40 parts of an aqueous solution containing 0.05 part of xanthan gum and 0.1 part of aluminium magnesium silicate is added and further 10 parts of propylene glycol is added. The mixture was stirred and mixed to give a flowable of each compound.
    • Formulation Example 3
  • 2 parts of each of the compounds 1 to 8 of the present invention, 88 parts of kaolin clay and 10 parts of talc are pulverized and mixed well to give a dust of each compound.
    • Formulation Example 4
  • 5 parts of each of the compounds 1 to 8 of the present invention, 14 parts of polyoxyethylenestyryl phenyl ether, 6 parts of calcium dodecylbenzenesulfonate and 75 parts of xylene are mixed well to give an emulsifiable concentrate of each compound.
    • Formulation Example 5
  • 2 parts of each of the compounds 1 to 8 of the present invention, 1 part of synthetic hydrated silica, 2 parts of calcium ligninsulfonate, 30 parts of bentonite and 65 parts of kaolin clay are pulverized and mixed well, and water is added thereto and kneeded well, granulated and dried to give granules of each compound.
    • Formulation Example 6
  • 10 parts of each of the compounds 1 to 8 of the present invention, 35 parts of white carbon containing 50 parts of ammonium polyoxyethylenealkyl ether sulfate, and 55 parts of water are mixed and wet pulverized finely to give a formulation of each compound.
  • The following Test Examples show that the compounds of the present invention are useful for controlling a plant disease.
    The controlling effect was evaluated by visually observing the area or a lesion spots on each of test plants at the time of investigation and comparing the area of lesion spots on a plant treated with the compound of the present invention with that on an untreated plant.
    • Test Example 1 Test of preventive effect on wheat powdery mildew (Erysiphe graminis f. sp. tritici)
  • Each of plastic pots was filled with sandy loam and sown with wheat (cultivar; Shiragane), followed by growing in a greenhouse for 10 days. Each of the compounds 2 and 3 of the present invention was formulated into a flowable formulation according to Formulation Example 6. The flowable formulation was diluted to a predetermined concentration (500 ppm) with water, and foliage application of the dilution was carried out so that the dilution adhered sufficiently to the surfaces of leaves of the grown wheat young seedling. After the foliage application, the plant was air-dried and then inoculated by sprinkling with spores of Erysipne graminis f. sp. tritici. After the inoculation, the plant was held in a greenhouse at 23°C for 7 days and the area of lesion spots was investigated. As a result, it was found that the area of lesion spots on the plant treated with each of the compounds 2 and 3 of the present invention was 30% or less of that on an untreated plant.
    • Test Example 2 Test of preventive effect on wheat Glume blotch (Stagonospora nodorum)
  • Each of plastic pots was filled with sandy loam and sown with wheat (cultivar; Shirogane), followed by growing in a greenhouse for 10 days. Each of the compounds 2 and 3 of the present invention was formulated into a flowable formulation according to Formulation Example 6. The flowable formulation was diluted to a predetermined concentration (500 ppm) with water, and foliage application of the dilution was carried out so that the dilution adhered sufficiently to the surfaces of leaves of the grown wheat young seedling. After the foliage application, the plant was air-dried and then inoculated by spraying a water suspension of spores of Stagonospora nodorum. After the inoculation, the plant was held under darkness and high humidity conditions at 18°C for 4 days and held under lighting conditions for 4 days, and thenthe area of lesion spots was investigated. As a result, it was found that the area of lesion spots on the plant treated with each of the compounds 2 or 3 of the present invention was 30% or less of that on an untreated plant.
    • Test Example 3 Test of preventive effect on wheat Fusarium blight (Fusarium culmorum)
  • Each of plastic pots was filled with sandy loam and sown with wheat (cultivar; Shirogane), followed by growing in a greenhouse for 10 days. The compound 1 of the present invention was formulated into a flowable formulation according to Formulation Example 6. The flowable formulation was diluted to a predetermined concentration (500 ppm) with water, and foliage application of the dilution was carried out so that the dilution adhered sufficiently to the surfaces of leaves of the grown wheat young seedling. After the foliage application, the plant was air-dried and then inoculated by spraying a water suspension of spores of Fusarium culmorum. After the inoculation, the plant was held under darkness and high humidity conditions at 23°C for 4 days and held under lighting conditions for 3 days, and then the area of lesion spots was investigated. As a result, it was found that the area of lesion spots on the plant treated with the compound 1 of the present invention was 30% or less of that on an untreated plant.
    • Test Example 4 Test of preventive effect on cucumber stem rot (Sclerotinia sclerotiorum)
  • Each of plastic pots was filled with sandy loam and sown with cucumber (variety; Sagamihanjiro), followed by growing in a greenhouse for 12 days. The compound 2 of the present invention was formulated into a flowable formulation according to Formulation Example 6. The flowable formulation was diluted to a predetermined concentration (500 ppm) with water, and foliage application of the dilution was carried out so that the dilution adhered sufficiently to the surfaces of leaves of the grown cucumber young seedling. After the foliage application, the plant was air-dried and a PDA medium containing mycelia of Sclerotinia sclerotiorum was placed on the surfaces of the cucumber leaves. After the inoculation, the plant was grown at 18°C and high humidity for 4 days. Then, the area of lesion spots was investigated. As a result, it was found that the area of lesion spots on the plant treated with the compound 2 of the present invention was 30% or less of that on an untreated plant.
    • Test Example 5 Test of preventive effect on tomato late blight (Phytophthora infestans)
  • Each of plastic pots was filled with sandy loam and sown with tomato (cultivar; Patio), followed by growing in a greenhouse for 20 days. Each of the compounds 3, 4 and 7 of the present invention was formulated into a flowable formulation according to Formulation Example 6. The flowable formulation was diluted to a predetermined concentration (500 ppm) with water, and foliage application of the dilution was carried out so that the dilution adhered sufficiently to the surfaces of leaves of the grown tomato young seedling. After the plant was air-dried so that the diluted solution on leaves was dried, a water suspension of zoosporangia of Phytophthora infestans was sprayed. After the inoculation, the plant was held under high humidity conditions at 23°C for 1 day and held in a greenhouse for 4 days, and then the area of lesion spots was investigated. As a result, it was found that the area of lesion spots on the plant treated with each of the compounds 3, 4 and 7 of the present invention was 30% or less of that an untreated plant.
    • Industrial Applicability
  • As described above, according to the present invention, an amide compound having excellent plant disease controlling activity which is useful as an active ingredient of a plant disease controlling agent can be provided.

Claims (7)

  1. An amide compound represented by the formula (1):
    Figure imgb0034
     wherein,
    X1 represents a fluorine atom or a methoxy group,
    X2 represents a chlorine atom, a bromine atom, an iodine atom, a C1-C4 alkyl group, a C2-C4 alkenyl group, a C2-C4 alkynyl group, a C1-C4 haloalkyl group, a C2-C4 alkoxy group, a C1-C4 alkylthio group, a hydroxy C1-C4 alkly group, a nitro group, a cyano group, a formyl group, a NR1R2 group, a CO2R3 group, a CONR4R5 group, or a phenyl group optionally substituted with at least one group selected from the group consisting of a methyl group, a halogen atom, a cyano group and a nitro group,
    Z represents an oxygen atom or a sulfur atom,
    A represents an A1-CR11R12R13 group or A2-Cy group,
    A1 represents a single bond or a CH2 group,
    A2 represents a single bond, a CH2 group, a CH(CH3) group, a C(CH3)2 group or a CH(CH2CH3) group,
    Cy represents a C3-C6 cycloalkyl group optionally substituted with at least one group selected from the group consisting of a C1-C4 alkyl group, a C2-C4 alkenyl group, a C2-C4 alkynyl group, a halogen atom, a hydroxyl group, a cyano group, a carboxyl and a C2-C5 alkoxycarbonyl group,
    R1 and R2 independently represent a hydrogen atom, a C1-C4 alkyl group, a C3-C4 alkenyl group, a C3-C4 alkynyl group, a C2-C4 haloalkyl group, a C2-C5 alkylcarbonyl group, a C2-C5 alkoxycarbonyl group or a C1-C4 alkylsulfonyl group,
    R3 represents a C1-C4 alkyl group, a C3-C4 alkenyl group or a C3-C4 alkynyl group,
    R4 represents a hydrogen atom, a C1-C4 alkyl group, a C3-C4 alkenyl group, a C3-C4 alkynyl group, a C2-C4 haloalkyl group, a C2-C5 alkylcarbonyl group, a C2-C5 alkoxycarbonyl group, or a C1-C4 alkylsulfonyl group,
    R5 represents a hydrogen atom, a C1-C4 alkyl group, a C3-C4 alkenyl group, a C3-C4 alkynyl group or a C2-C4 haloalkyl group,
    R11 and R12 independently represent a C1-C4 alkyl group, and
    R13 represents a hydrogen atom, a C1-C4 alkyl group, a C2-C4 alkenyl group, a C2-C4 alkynyl group, a cyano group, a carboxyl group or a C2-C5 alkoxycarbonyl group.
  2. The amide compound according to claim 1, wherein X1 is a fluorine atom in the formula (1).
  3. The amide compound according to claim 1, wherein X1 is a methoxy group in the formula (1).
  4. The amide compound according to claim 1, wherein A is A1-CR11R12R13 and R13 is a hydrogen atom or a methyl group in the formula (1).
  5. The amide compound according to claim 1, wherein A is A2-Cy and Cy is a C3-C6 cycloalkyl group optionally substituted with at least one group selected from the group consisting of a C1-C4 alkyl group, a halogen atom, a hydroxyl group and a cyano group in the formula (1).
  6. A plant disease controlling agent comprising the amide compound according to any one of claims 1 to 5 as an active ingredient.
  7. A method of controlling a plant disease which comprises treating a plant or soil with an effective amount of the amide compound according to any one of claims 1 to 5.
EP08752105A 2007-04-27 2008-04-25 Amide compound and use thereof Withdrawn EP2151431A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007118646 2007-04-27
PCT/JP2008/058031 WO2008136387A1 (en) 2007-04-27 2008-04-25 Amide compound and use thereof

Publications (2)

Publication Number Publication Date
EP2151431A1 true EP2151431A1 (en) 2010-02-10
EP2151431A4 EP2151431A4 (en) 2010-04-21

Family

ID=39943496

Family Applications (1)

Application Number Title Priority Date Filing Date
EP08752105A Withdrawn EP2151431A4 (en) 2007-04-27 2008-04-25 Amide compound and use thereof

Country Status (5)

Country Link
US (1) US20100069499A1 (en)
EP (1) EP2151431A4 (en)
JP (1) JP2008291023A (en)
BR (1) BRPI0810498A2 (en)
WO (1) WO2008136387A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019081486A1 (en) 2017-10-24 2019-05-02 Bayer Aktiengesellschaft 4h-pyrrolo[3,2-c]pyridin-4-one derivatives
WO2020216774A1 (en) 2019-04-24 2020-10-29 Bayer Aktiengesellschaft 4h-pyrrolo[3,2-c]pyridin-4-one derivatives
WO2020216781A1 (en) 2019-04-24 2020-10-29 Bayer Aktiengesellschaft 4h-pyrrolo[3,2-c]pyridin-4-one compounds
WO2020216773A1 (en) 2019-04-24 2020-10-29 Bayer Aktiengesellschaft 4h-pyrrolo[3,2-c]pyridin-4-one compounds
WO2021198020A1 (en) 2020-03-31 2021-10-07 Bayer Aktiengesellschaft 3-(anilino)-2-[3-(3-alkoxy-pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one derivatives as egfr inhibitors for the treatment of cancer

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2143709A4 (en) 2007-04-27 2010-04-28 Sumitomo Chemical Co Amide compound and use thereof
JP2008291012A (en) 2007-04-27 2008-12-04 Sumitomo Chemical Co Ltd Amide compound and use thereof for controlling plant disease injury
JP2008291013A (en) 2007-04-27 2008-12-04 Sumitomo Chemical Co Ltd Amide compound and use thereof for controlling plant disease injury
WO2010145789A1 (en) 2009-06-18 2010-12-23 Bayer Cropscience Ag Propargyloxybenzamide derivatives

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1770085A1 (en) * 2004-07-21 2007-04-04 Mitsui Chemicals, Inc. Diamine derivative, process for producing the same and fungicide containing the derivative as active ingredient

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR8600161A (en) 1985-01-18 1986-09-23 Plant Genetic Systems Nv CHEMICAL GENE, HYBRID, INTERMEDIATE PLASMIDIO VECTORS, PROCESS TO CONTROL INSECTS IN AGRICULTURE OR HORTICULTURE, INSECTICIDE COMPOSITION, PROCESS TO TRANSFORM PLANT CELLS TO EXPRESS A PLANTINIDE TOXIN, PRODUCED BY CULTURES, UNITED BY BACILLA
JPH0749379B2 (en) * 1985-12-27 1995-05-31 住友化学工業株式会社 Substituted benzene derivative and agricultural and horticultural fungicide containing the same as active ingredient
JPS63154601A (en) * 1986-12-16 1988-06-27 Sumitomo Chem Co Ltd Agricultural a
CA1340685C (en) 1988-07-29 1999-07-27 Frederick Meins Dna sequences encoding polypeptides having beta-1,3-glucanase activity
CA2005658A1 (en) 1988-12-19 1990-06-19 Eliahu Zlotkin Insecticidal toxins, genes encoding these toxins, antibodies binding to them and transgenic plant cells and plants expressing these toxins
DK0392225T3 (en) 1989-03-24 2003-09-22 Syngenta Participations Ag Disease resistant transgenic plants
ES2074547T3 (en) 1989-11-07 1995-09-16 Pioneer Hi Bred Int LARVICID LECTINES, AND INDUCED RESISTANCE OF PLANTS TO INSECTS.
US5639949A (en) 1990-08-20 1997-06-17 Ciba-Geigy Corporation Genes for the synthesis of antipathogenic substances
UA48104C2 (en) 1991-10-04 2002-08-15 Новартіс Аг Dna fragment including sequence that codes an insecticide protein with optimization for corn, dna fragment providing directed preferable for the stem core expression of the structural gene of the plant related to it, dna fragment providing specific for the pollen expression of related to it structural gene in the plant, recombinant dna molecule, method for obtaining a coding sequence of the insecticide protein optimized for corn, method of corn plants protection at least against one pest insect
US5530195A (en) 1994-06-10 1996-06-25 Ciba-Geigy Corporation Bacillus thuringiensis gene encoding a toxin active against insects
HUP0203961A3 (en) * 2000-01-25 2003-05-28 Syngenta Participations Ag 3-phenoxy-1-phenyl acetylene derivatives and their use as herbicedes
WO2003000906A2 (en) 2001-06-22 2003-01-03 Syngenta Participations Ag Plant disease resistance genes
AR035087A1 (en) * 2001-08-09 2004-04-14 Syngenta Participations Ag PIRIDIL-ALQUINOS AND PIRIDIL-N-OXIDO-ACTIVE HERBICIDE ALKINES, PROCEDURE FOR PREPARATION, HERBICIDE COMPOSITION AND TO INHIBIT THE GROWTH OF PLANTS, METHOD FOR CONTROLLING GROWTH OF INDESEABLE PLANTS, AND METHOD OF CREAM INHIBITION
AU2002361696A1 (en) 2001-12-17 2003-06-30 Syngenta Participations Ag Novel corn event
JP4520912B2 (en) * 2004-07-21 2010-08-11 三井化学アグロ株式会社 Diamine derivatives, process for producing the same, and fungicides containing them as active ingredients
WO2007049728A1 (en) * 2005-10-27 2007-05-03 Sumitomo Chemical Company, Limited Amide compounds and their use
JP2007145817A (en) * 2005-10-27 2007-06-14 Sumitomo Chemical Co Ltd Amide compound and its use
JP2007145816A (en) * 2005-10-27 2007-06-14 Sumitomo Chemical Co Ltd Amide compound and its use
WO2007049729A2 (en) * 2005-10-27 2007-05-03 Sumitomo Chemical Company, Limited Amide compounds and their use
JP2008291012A (en) * 2007-04-27 2008-12-04 Sumitomo Chemical Co Ltd Amide compound and use thereof for controlling plant disease injury
JP2008291013A (en) * 2007-04-27 2008-12-04 Sumitomo Chemical Co Ltd Amide compound and use thereof for controlling plant disease injury
EP2143709A4 (en) * 2007-04-27 2010-04-28 Sumitomo Chemical Co Amide compound and use thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1770085A1 (en) * 2004-07-21 2007-04-04 Mitsui Chemicals, Inc. Diamine derivative, process for producing the same and fungicide containing the derivative as active ingredient

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2008136387A1 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019081486A1 (en) 2017-10-24 2019-05-02 Bayer Aktiengesellschaft 4h-pyrrolo[3,2-c]pyridin-4-one derivatives
WO2020216774A1 (en) 2019-04-24 2020-10-29 Bayer Aktiengesellschaft 4h-pyrrolo[3,2-c]pyridin-4-one derivatives
WO2020216781A1 (en) 2019-04-24 2020-10-29 Bayer Aktiengesellschaft 4h-pyrrolo[3,2-c]pyridin-4-one compounds
WO2020216773A1 (en) 2019-04-24 2020-10-29 Bayer Aktiengesellschaft 4h-pyrrolo[3,2-c]pyridin-4-one compounds
WO2021198020A1 (en) 2020-03-31 2021-10-07 Bayer Aktiengesellschaft 3-(anilino)-2-[3-(3-alkoxy-pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one derivatives as egfr inhibitors for the treatment of cancer

Also Published As

Publication number Publication date
US20100069499A1 (en) 2010-03-18
BRPI0810498A2 (en) 2014-10-14
WO2008136387A1 (en) 2008-11-13
EP2151431A4 (en) 2010-04-21
JP2008291023A (en) 2008-12-04

Similar Documents

Publication Publication Date Title
US7999136B2 (en) Amide compound and use thereof
US20100069499A1 (en) Amide compound and use thereof
US7956010B2 (en) Amide compound and use thereof for controlling plant diseases
US20100137376A1 (en) Amide compound and method for controlling plant disease using the same
US8003699B2 (en) Amide compound and use thereof for controlling plant diseases
US20130296436A1 (en) Amidine compounds and use thereof for plant disease control
WO2010024422A1 (en) Amide compounds and use thereof
US20100137445A1 (en) Plant disease control agent, and plant disease control method
US20100311790A1 (en) Amide compounds and plant disease controlling method using same
EP2222655B1 (en) N-cycl0alkylmethyl-2-amin0thiaz0le-5-carb0xamides for use in plant disease control
JP2009029798A (en) Plant disease control agent, and plant disease control method
JP2009029799A (en) Plant disease-controlling agent and method for controlling plant disease
US20100227884A1 (en) Amide compounds and plant disease controlling method using same
JP2009235055A (en) Anilide compound, and its use for controlling plant disease
JP2009120587A (en) Amide compound and its use
JP2009256263A (en) Amide compound and its use for plant disease control
JP2010030989A (en) Amide compound, and its use in controlling plant disease
JP2009114178A (en) Amide compound and application of the same for controlling plant disease injury
JP2010270035A (en) Amide compound, and use therefor in controlling plant disease
JP2008273849A (en) Phenethylamide compound and plant disease control agent containing the same
TW201010989A (en) Amide compound and use thereof
WO2009093637A1 (en) Amide compound and use thereof
JP2009096732A (en) Amide compound and its plant disease control use

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20091124

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA MK RS

A4 Supplementary search report drawn up and despatched

Effective date: 20100324

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20101008

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20120313